News and Press Release

Base Context

array:10 [
  "http_host" => "https://preprod.lbofrance.com"
  "wp_title" => "News and Press Release - Page 8 of 11 - LBO France"
  "body_class" => "blog paged paged-8"
  "site" => Site {#397
    +admin_email: "admin@adveris.fr"
    +blogname: null
    +charset: "UTF-8"
    +description: ""
    +id: null
    +language: "en_US"
    +multisite: false
    +name: "LBO France"
    +pingback_url: "https://preprod.lbofrance.com/xmlrpc.php"
    +siteurl: null
    +theme: Theme {#417
      +name: "Yagami"
      +version: ""
      +parent: false
      +parent_slug: null
      +slug: "yagami"
      +uri: "https://preprod.lbofrance.com/wp-content/themes/yagami"
      -theme: WP_Theme {#414
        +update: false
        -theme_root: "/var/www/lbofrance.com/docs/wp-content/themes"
        -headers: array:14 [
          "Name" => "Yagami"
          "ThemeURI" => ""
          "Description" => "Custom starter to build wordpress theme from scratch"
          "Author" => "Kévin Vacherot"
          "AuthorURI" => "https://www.linkedin.com/in/k%C3%A9vin-vacherot-b9a004a2/"
          "Version" => ""
          "Template" => ""
          "Status" => ""
          "Tags" => "yagami, blank"
          "TextDomain" => "Yagami"
          "DomainPath" => ""
          "RequiresWP" => ""
          "RequiresPHP" => ""
          "UpdateURI" => ""
        ]
        -headers_sanitized: array:2 [
          "Name" => "Yagami"
          "Version" => ""
        ]
        -block_theme: false
        -name_translated: null
        -errors: null
        -stylesheet: "yagami"
        -template: "yagami"
        -parent: null
        -theme_root_uri: "https://preprod.lbofrance.com/wp-content/themes"
        -textdomain_loaded: null
        -cache_hash: "37a7699c69410d0bf18f875580b71453"
        -block_template_folders: array:2 [
          "wp_template" => "templates"
          "wp_template_part" => "parts"
        ]
        -default_template_folders: array:2 [
          "wp_template" => "templates"
          "wp_template_part" => "parts"
        ]
      }
      +id: null
      +ID: null
      +object_type: null
    }
    +title: "LBO France"
    +url: "https://preprod.lbofrance.com/en/"
    +home_url: "https://preprod.lbofrance.com/en/"
    +site_url: "https://preprod.lbofrance.com"
    +rdf: "https://preprod.lbofrance.com/en/feed/rdf/"
    +rss: "https://preprod.lbofrance.com/en/feed/rss/"
    +rss2: "https://preprod.lbofrance.com/en/feed/"
    +atom: "https://preprod.lbofrance.com/en/feed/atom/"
    +ID: null
    +object_type: null
    +"pingback": "https://preprod.lbofrance.com/xmlrpc.php"
  }
  "request" => Request {#419
    +post: []
    +get: []
    +id: null
    +ID: null
    +object_type: null
  }
  "user" => false
  "theme" => Theme {#417}
  "posts" => PostQuery {#415
    +found_posts: 91
    #userQuery: false
    #queryIterator: QueryIterator {#413
      -_query: WP_Query {#5122
        +query: array:2 [
          "paged" => "8"
          "pagename" => "news-and-press-release"
        ]
        +query_vars: array:66 [
          "paged" => 8
          "pagename" => "news-and-press-release"
          "error" => ""
          "m" => ""
          "p" => 0
          "post_parent" => ""
          "subpost" => ""
          "subpost_id" => ""
          "attachment" => ""
          "attachment_id" => 0
          "name" => ""
          "page_id" => 0
          "second" => ""
          "minute" => ""
          "hour" => ""
          "day" => 0
          "monthnum" => 0
          "year" => 0
          "w" => 0
          "category_name" => ""
          "tag" => ""
          "cat" => ""
          "tag_id" => ""
          "author" => ""
          "author_name" => ""
          "feed" => ""
          "tb" => ""
          "meta_key" => ""
          "meta_value" => ""
          "preview" => ""
          "s" => ""
          "sentence" => ""
          "title" => ""
          "fields" => ""
          "menu_order" => ""
          "embed" => ""
          "category__in" => []
          "category__not_in" => []
          "category__and" => []
          "post__in" => []
          "post__not_in" => []
          "post_name__in" => []
          "tag__in" => []
          "tag__not_in" => []
          "tag__and" => []
          "tag_slug__in" => []
          "tag_slug__and" => []
          "post_parent__in" => []
          "post_parent__not_in" => []
          "author__in" => []
          "author__not_in" => []
          "search_columns" => []
          "meta_query" => []
          "ignore_sticky_posts" => false
          "suppress_filters" => false
          "cache_results" => true
          "update_post_term_cache" => true
          "update_menu_item_cache" => false
          "lazy_load_term_meta" => true
          "update_post_meta_cache" => true
          "post_type" => ""
          "posts_per_page" => 9
          "nopaging" => false
          "comments_per_page" => "50"
          "no_found_rows" => false
          "order" => "DESC"
        ]
        +tax_query: WP_Tax_Query {#7737
          +queries: []
          +relation: "AND"
          #table_aliases: []
          +queried_terms: []
          +primary_table: "lbo_posts"
          +primary_id_column: "ID"
        }
        +meta_query: WP_Meta_Query {#7739
          +queries: []
          +relation: null
          +meta_table: null
          +meta_id_column: null
          +primary_table: null
          +primary_id_column: null
          #table_aliases: []
          #clauses: []
          #has_or_relation: false
        }
        +date_query: false
        +queried_object: WP_Post {#7738
          +ID: 2124
          +post_author: "1"
          +post_date: "2019-04-11 10:41:31"
          +post_date_gmt: "2019-04-11 08:41:31"
          +post_content: ""
          +post_title: "News and Press Release"
          +post_excerpt: ""
          +post_status: "publish"
          +comment_status: "closed"
          +ping_status: "closed"
          +post_password: ""
          +post_name: "news-and-press-release"
          +to_ping: ""
          +pinged: ""
          +post_modified: "2020-01-13 18:42:25"
          +post_modified_gmt: "2020-01-13 17:42:25"
          +post_content_filtered: ""
          +post_parent: 0
          +guid: "http://preprod.lbofrance.com/actualites/"
          +menu_order: 34
          +post_type: "page"
          +post_mime_type: ""
          +comment_count: "0"
          +filter: "raw"
        }
        +queried_object_id: 2124
        +request: """
          SELECT SQL_CALC_FOUND_ROWS  lbo_posts.ID\n
          \t\t\t\t\t FROM lbo_posts  JOIN lbo_icl_translations wpml_translations\n
          \t\t\t\t\t\t\tON lbo_posts.ID = wpml_translations.element_id\n
          \t\t\t\t\t\t\t\tAND wpml_translations.element_type = CONCAT('post_', lbo_posts.post_type) \n
          \t\t\t\t\t WHERE 1=1  AND ((lbo_posts.post_type = 'post' AND (lbo_posts.post_status = 'publish' OR lbo_posts.post_status = 'acf-disabled'))) AND ( ( ( wpml_translations.language_code = 'en' OR 0 ) AND lbo_posts.post_type  IN ('post','page','attachment','wp_block','wp_template','wp_template_part','wp_navigation','members','investments' )  ) OR lbo_posts.post_type  NOT  IN ('post','page','attachment','wp_block','wp_template','wp_template_part','wp_navigation','members','investments' )  )\n
          \t\t\t\t\t \n
          \t\t\t\t\t ORDER BY lbo_posts.post_date DESC\n
          \t\t\t\t\t LIMIT 63, 9
          """
        +posts: & array:9 [
          0 => WP_Post {#7741
            +ID: 2142
            +post_author: "1"
            +post_date: "2017-12-13 09:04:04"
            +post_date_gmt: "2017-12-13 08:04:04"
            +post_content: """
              <strong>Paris, on December 13th 2017</strong> – LBO France announces today that it has entered into a definitive agreement for the acquisition of Crouzet (the “Company”), a worldwide leader specialized in customized switches, electric actuators and automated systems for critical applications, from InnoVista Sensors, a company owned by PAI Partners, The Carlyle Group and Schneider Electric. The transaction has already received a favorable opinion from the relevant works council and remains subject to customary regulatory approvals. The transaction is expected to close by early 2018.\r\n
              \r\n
              Founded in 1921 and today comprising approximately 1,200 employees, the Company serves diversified end-markets, including aerospace &amp; industry, transportation, energy &amp; infrastructure and other industries, through 3 principal production sites (France, Morocco and China). In 2016, Crouzet generated €136 million in sales, 74% of which outside France.\r\n
              \r\n
              As a result of its technical expertise and longstanding industrial history, Crouzet has gained strong recognition of leadership over the years and secured privileged relationships with its clients.\r\n
              \r\n
              In addition, the Company’s client base is highly diversified with more than 1,000 active customers.\r\n
              \r\n
              <strong>Thomas Boulman, Partner at LBO France</strong>, commented: <em>"This investment in Crouzet illustrates LBO France’s strategy of partnering with leaders in attractive niche sectors with recognized technological expertise customization capabilities, critical applications supplying and international geographical coverage. We have been impressed and comforted by the work done in the past years by the management under the joint ownership of PAI Partners, The Carlyle Group and Schneider Electric. We are now excited to team up with the management to support the Company on its new development phase and are eager to accelerate Crouzet’s ambitious strategy of product and technological innovation, market and geography deployment as well as selected build-up acquisitions." </em>\r\n
              \r\n
              <strong>David Arragon, CEO of Crouzet</strong>, added: <em>"With the support of LBO France as its new shareholder, we are confident on Crouzet’s capacity to carry on its development strategy and to consolidate its worldwide leadership on its niche markets.</em>"\r\n
              \r\n
              LBO France (Thomas Boulman, Simon Couturier, Eva Hoël, Philippe Karmin) was advised on this transaction by Advention (Alban Neveux, Eric Lesavre) on the strategic due diligence, EY Transaction Services (Jean-François Nadaud, Renaud Régner) on the financial due diligence and Mayer Brown for legal (Thomas Philippe, Clotilde Billat, Estelle Leclerc, Mélisande Sauze), tax (Elodie Deschamps, Olivia Sibieude) and financing (Patrick Teboul, Maud Bischoff, Julien Leris) matters.\r\n
              \r\n
              InnoVista Sensors was advised on this transaction by Canaccord Genuity (Nadim Barouki, Nicolas Royer), Latham &amp; Watkins (Alexander Benedetti, Julie Tchaglass, Alexandre Balat) on legal and corporate aspects, Linklaters (Oliver Sceales, Alex Szehidewicz) on legal and financing aspects\r\n
              \r\n
              Crouzet management was advised on this transaction by Delaby Dorison (Emmanuel Delaby, Florian Tumoine) for tax aspects and Bremond &amp; Associés (Christine Le Breton) for legal matters.\r\n
              \r\n
              - - -\r\n
              \r\n
              <strong>About LBO France</strong>\r\n
              \r\n
              As a key player in private equity with €3.6 bn of capital under management, LBO France is an independent company that has been supporting French companies in their growth for more than 30 years. Its strategy is based on 4 investment approaches in non-listed assets, managed by dedicated teams: (i) Mid Cap Buyout through the White Knight funds and Small Cap Buyout through the Hexagone/Small Caps Opportunities funds, (ii) Venture Capital through the SISA fund, (iii) Real Estate through the White Stone and Lapillus funds, (iv) Debt. LBO France is 100%-owned by its management and employs nearly 60 professionals.\r\n
              \r\n
              <a href="http://www.lbofrance.com">www.lbofrance.com</a>\r\n
              \r\n
              About Crouzet Since 1921, Crouzet has been committed to designing, manufacturing and supplying efficient components for automated systems to serve a wide range of applications in the Aerospace &amp; Defense market and in many Industrial equipment markets with a specific focus on applications such as Access control, Railway, Nuclear and Industrial valves markets.\r\n
              \r\n
              Crouzet’s product lines include Automation and Control devices, Motion products, Switches and Position Sensors, Cockpit Controls and (i) Electrical Protection solutions.\r\n
              \r\n
              Crouzet has a heritage of close collaboration with customers in the development of adapted products to fully customized solutions.\r\n
              \r\n
              Driven by innovation and customer satisfaction our teams are focused on delivering the right products and services for the right application, always meeting, often exceeding customers’ expectations.\r\n
              \r\n
              Crouzet is your trusted partner of choice to face industrial challenges of today and tomorrow.\r\n
              \r\n
              Crouzet is a company of InnoVista SensorsTM.\r\n
              \r\n
              <strong>Media Contacts</strong>\r\n
              \r\n
              For LBO France\r\n
              \r\n
              Citigate Dewe Rogerson\r\n
              \r\n
              Robert Amady - +33 1 53 32 78 91 - robert.amady@citigatedewerogerson.com\r\n
              \r\n
              Daiana Hirte - +33 1 53 32 78 90 - daiana.hirte@citigatedewerogerson.com\r\n
              \r\n
              For PAI Partners\r\n
              \r\n
              Greenbrook Communications:\r\n
              \r\n
              James Madsen / Annabel Clay (+44 20 7952 2000)\r\n
              \r\n
              DGM:\r\n
              \r\n
              Michel Calzaroni / Olivier Labesse / Hugues Schmitt (+33 1 40 70 11 89)\r\n
              \r\n
              For The Carlyle Group\r\n
              \r\n
              media.europe@carlyle.com\r\n
              \r\n
              and\r\n
              \r\n
              Steele &amp; Holt PR Agency\r\n
              \r\n
              Daphné Claude\r\n
              \r\n
              daphne@steeleandholt.com\r\n
              \r\n
              +33 6 66 58 81 92\r\n
              \r\n
              For Schneider Investor Relations (Schneider Electric):\r\n
              \r\n
              Amit Bhalla (+44 20 7592 8216)\r\n
              \r\n
              <strong>Press contact (Schneider Electric):</strong>\r\n
              \r\n
              Véronique Roquet-Montégon (+33 (0)1 41 29 70 76)\r\n
              \r\n
              <strong>Press Contact (DGM):</strong>\r\n
              \r\n
              Michel Calzaroni and Olivier Labesse (+33 (0)1 40 70 11 89)\r\n
              \r\n
              For Crouzet Françoise KAYZAKIAN | Communication Director\r\n
              \r\n
              Tel: 00 33 4 75 44 89 01\r\n
              \r\n
              E-mail : francoise.kayzakian@innovistasensors.com\r\n
              \r\n
              &nbsp;\r\n
              \r\n
              &nbsp;\r\n
              \r\n
              <a href="https://preprod.lbofrance.com/wp-content/uploads/2019/12/lbo-france-crouzet-eng-13122017.pdf">Read Press Release</a>
              """
            +post_title: "LBO France enters into a final agreement to acquire Crouzet"
            +post_excerpt: ""
            +post_status: "publish"
            +comment_status: "open"
            +ping_status: "closed"
            +post_password: ""
            +post_name: "lbo-france-enters-into-a-final-agreement-to-acquire-crouzet"
            +to_ping: ""
            +pinged: ""
            +post_modified: "2020-02-11 15:09:36"
            +post_modified_gmt: "2020-02-11 14:09:36"
            +post_content_filtered: ""
            +post_parent: 0
            +guid: "http://preprod.lbofrance.com/lbo-france-signe-un-accord-final-pour-lacquisition-de-crouzet/"
            +menu_order: 0
            +post_type: "post"
            +post_mime_type: ""
            +comment_count: "0"
            +filter: "raw"
            +"status": "publish"
            +"id": 2142
            +"slug": "lbo-france-enters-into-a-final-agreement-to-acquire-crouzet"
            +"custom": array:16 [
              "_wpml_media_featured" => "1"
              "_wpml_media_duplicate" => "1"
              "_yoast_wpseo_content_score" => "30"
              "_wp_old_date" => "2019-12-18"
              "banner" => ""
              "_banner" => "field_5d0b8f67a8a14"
              "linkedin" => ""
              "_linkedin" => "field_5d0b8fa0a8a15"
              "fichier" => ""
              "_fichier" => "field_5d0b8faba8a16"
              "_yoast_wpseo_primary_category" => ""
              "_edit_lock" => "1581430034:1"
              "_edit_last" => "1"
              "_wp_old_slug" => "lbo-france-signe-un-accord-final-pour-lacquisition-de-crouzet"
              "_last_translation_edit_mode" => "native-editor"
              "_wpml_media_has_media" => "1"
            ]
          }
          1 => WP_Post {#7740
            +ID: 2143
            +post_author: "1"
            +post_date: "2017-11-30 09:05:25"
            +post_date_gmt: "2017-11-30 08:05:25"
            +post_content: """
              <strong>Paris, Dec. 1 st 2017</strong> – LBO France today announced the acquisition of Bexley (“the Company”), a French specialty retailer of men’s high quality footwear at affordable price. The founding manager, Mr. Eric Botton, will keep a minority interest in the Company.\r\n
              \r\n
              Founded in 1985, Bexley rapidly established itself as one of the most successful French retailers of men’s footwear positioned in the affordable luxury segment and offering excellent quality-price ratio. Since then, the Company gradually diversified its product offering with men’s clothing (shirts, polos, pullovers, pants and suits) and accessories (belts, socks and small leather goods).\r\n
              \r\n
              In addition to its own store network, Bexley, which was a precursor in developing an omni-channel strategy, succeeded in setting up and launching an effective e-commerce platform as early as 1996, which today accounts for 1/3 of total sales with more than 400,000 customers.\r\n
              \r\n
              The Company employs 75 employees split between its head-office in Lyon and its 14 stores located in Paris, Lyon, Annecy, Aix, Marseille and Brussels.\r\n
              \r\n
              To accelerate growth and expansion in the coming years, Bexley has identified 3 main priorities:\r\n
              \r\n
              - Further develop its e-commerce platform focusing on the acquisition of new clients, its CRM tool, and an enhanced customer experience thanks to shopping via smartphones or tablets;\r\n
              \r\n
              - Continue geographical expansion in France with the opening of new stores in other French large cities or selected mid-sized cities;\r\n
              \r\n
              - Proactively identify prime location opportunities for new store openings in large European cities such as London or Berlin.\r\n
              \r\n
              Jérôme Guez, Partner LBO France, commented: <em>"We are very enthusiastic about this 5 th investment of our Mid Cap fund White Knight IX in Bexley. We look forward to work alongside the founding manager, Eric Botton, and his team in order to accompany Bexley in this new development chapter, by extending its store network, enhancing its e-commerce platform while maintaining very high profitability." </em>\r\n
              \r\n
              Eric Botton, Bexley’s founding manager, added: "I am very pleased to pursue Bexley’s growth story with LBO France, a financial sponsor in which, with the support of their Operating team, we have found a real understanding of our challenges and the clear willingness to invest alongside us in giving a whole new dimension to Bexley."\r\n
              \r\n
              Parties involved:\r\n
              \r\n
              LBO France\r\n
              \r\n
              - LBO France Team : Jérôme Guez, Guy Latourette, Laurent Mabileau, Karine Callec\r\n
              \r\n
              - Finance : 8 Advisory (Florence Khayat)\r\n
              \r\n
              - Legal : Mayer Brown (Xavier Jaspar ; Emily Pennec) Jones Day (Diane Sénéchal)\r\n
              \r\n
              - Strategy : Advention (Alban Neveu)\r\n
              \r\n
              - Tax : Arsene Taxand (Denis Andres)\r\n
              \r\n
              - - -\r\n
              \r\n
              <strong>About LBO France</strong>\r\n
              \r\n
              As a key player in private equity with €3.6bn of capital under management, LBO France is an independent company that has been supporting French companies in their growth for more than 30 years. Its strategy is based on 4 investment approaches in nonlisted assets, managed by dedicated teams: (i) Mid Cap Buyout through the White Knight funds and Small Cap Buyout through the Hexagone/Small Caps Opportunities funds, (ii) Venture Capital through the SISA fund, (iii) Real Estate through the White Stone and Lapillus funds, (iv) Debt. LBO France is 100%-owned by its management and employs nearly 60 professionals.\r\n
              \r\n
              <a href="http://www.lbofrance.com">www.lbofrance.com</a>\r\n
              \r\n
              <strong>Media Contacts</strong>\r\n
              \r\n
              For LBO France - Citigate Dewe Rogerson\r\n
              \r\n
              Robert Amady - +33 1 53 32 78 91 - robert.amady@citigatedewerogerson.com\r\n
              \r\n
              Daiana Hirte - +33 1 53 32 78 90 - daiana.hirte@citigatedewerogerson.com\r\n
              \r\n
              &nbsp;\r\n
              \r\n
              &nbsp;\r\n
              \r\n
              <a href="https://preprod.lbofrance.com/wp-content/uploads/2019/12/171201-lbo-france-pr-acq-bexley-final.pdf" target="_blank" rel="noopener noreferrer">Read Press Release</a>
              """
            +post_title: "LBO France announced the acquisition of Bexley"
            +post_excerpt: ""
            +post_status: "publish"
            +comment_status: "open"
            +ping_status: "closed"
            +post_password: ""
            +post_name: "lbo-france-announced-the-acquisition-of-bexley"
            +to_ping: ""
            +pinged: ""
            +post_modified: "2020-02-11 15:09:47"
            +post_modified_gmt: "2020-02-11 14:09:47"
            +post_content_filtered: ""
            +post_parent: 0
            +guid: "http://preprod.lbofrance.com/lbo-france-annonce-lacquisition-de-bexley/"
            +menu_order: 0
            +post_type: "post"
            +post_mime_type: ""
            +comment_count: "0"
            +filter: "raw"
            +"status": "publish"
            +"id": 2143
            +"slug": "lbo-france-announced-the-acquisition-of-bexley"
            +"custom": array:16 [
              "_wpml_media_featured" => "1"
              "_wpml_media_duplicate" => "1"
              "_yoast_wpseo_content_score" => "30"
              "_wp_old_date" => "2019-12-18"
              "banner" => ""
              "_banner" => "field_5d0b8f67a8a14"
              "linkedin" => ""
              "_linkedin" => "field_5d0b8fa0a8a15"
              "fichier" => ""
              "_fichier" => "field_5d0b8faba8a16"
              "_yoast_wpseo_primary_category" => ""
              "_edit_lock" => "1581430046:1"
              "_edit_last" => "1"
              "_wp_old_slug" => "lbo-france-annonce-lacquisition-de-bexley"
              "_last_translation_edit_mode" => "native-editor"
              "_wpml_media_has_media" => "1"
            ]
          }
          2 => WP_Post {#7746
            +ID: 2144
            +post_author: "1"
            +post_date: "2017-11-17 09:49:10"
            +post_date_gmt: "2017-11-17 08:49:10"
            +post_content: "<a href="https://preprod.lbofrance.com/wp-content/uploads/2019/12/journa-e-digitale-lbo-france-17-11-2016.pdf" target="_blank" rel="noopener noreferrer">Read Press Release</a>"
            +post_title: "Digital day LBO France - November 17, 2016"
            +post_excerpt: ""
            +post_status: "publish"
            +comment_status: "open"
            +ping_status: "closed"
            +post_password: ""
            +post_name: "digital-day-lbo-france-november-17-2016"
            +to_ping: ""
            +pinged: ""
            +post_modified: "2019-12-25 11:45:42"
            +post_modified_gmt: "2019-12-25 10:45:42"
            +post_content_filtered: ""
            +post_parent: 0
            +guid: "http://preprod.lbofrance.com/journee-digitale-lbo-france-17-novembre-2016/"
            +menu_order: 0
            +post_type: "post"
            +post_mime_type: ""
            +comment_count: "0"
            +filter: "raw"
            +"status": "publish"
            +"id": 2144
            +"slug": "digital-day-lbo-france-november-17-2016"
            +"custom": array:14 [
              "_yoast_wpseo_content_score" => "60"
              "banner" => ""
              "_banner" => "field_5d0b8f67a8a14"
              "linkedin" => ""
              "_linkedin" => "field_5d0b8fa0a8a15"
              "fichier" => ""
              "_fichier" => "field_5d0b8faba8a16"
              "_yoast_wpseo_primary_category" => ""
              "_wpml_media_duplicate" => "1"
              "_wpml_media_featured" => "1"
              "_edit_lock" => "1581430076:1"
              "_edit_last" => "1"
              "_wp_old_slug" => "journee-digitale-lbo-france-17-novembre-2016"
              "_last_translation_edit_mode" => "native-editor"
            ]
          }
          3 => WP_Post {#7749
            +ID: 2145
            +post_author: "1"
            +post_date: "2017-09-28 09:06:27"
            +post_date_gmt: "2017-09-28 07:06:27"
            +post_content: """
              <strong>Wandercraft, world leader in autonomous exos</strong>\r\n
              \r\n
              Wandercraft leverages the most advanced robotics to let wheelchair users walk again.\r\n
              \r\n
              Founded in 2012, Wandercraft is the first company in the world to master the technologies required to design and control autonomous exos capable of human-like walk.\r\n
              \r\n
              Wandercraft has built a disruptive technological advantage in the algorithms of dynamic robotics that allow to mimic a human walker by creating a balanced gait from permanent unbalance, and in mechatronics and bio-mechanics.\r\n
              \r\n
              These breakthroughs have been achieved by one of the world’s best walk robotics team, gathering in Paris 30 experts in robotics, algorithms, clinical trials, quality, regulation and marketing. Wandercraft is actively hiring new talents in these fields.\r\n
              \r\n
              The company will communicate soon on the successful clinical trials of the exo’s version designed for rehabilitation centers. Other clinical trials are planned to prove that exos delivering a realistic walk should enable more effective treatments in rehabilitation centers, and provide mobility-impaired persons with autonomy in their daily living.\r\n
              \r\n
              Autonomous exos will change the lives of millions of wheelchair users and of their physicians, physios and carers.\r\n
              \r\n
              <strong> Top-notch investors to break the disability barrier</strong>\r\n
              \r\n
              After a 5-year stealth period, Wandercraft’s team announces the closing of a Series B round of €15 million with five top-tier investors : XAnge, IDinvest, Cemag Invest and Bpifrance, followed by the company’s historical shareholder LBO France.\r\n
              \r\n
              The funds raised will contribute to scaling Wandercraft’s team, obtaining the exo approval from healthcare authorities, entering the global rehabilitation center market and developing the exo’s personal version.\r\n
              \r\n
              <strong>Nicolas Simon, CEO and one of the three founders of Wandercraft</strong>, has declared: <em>« We are proud to have built a fantastic investor team around our mission, to bring autonomy to wheelchair users. They do not only bring funding but a unique combined experience in robotics, medical technologies and global growth. With the success of the first clinical trials and after 5 years of development on the leading edge of robotics and medicine, we now have all the resources needed to enter the market and contribute to breaking the disability barrier.” </em>\r\n
              \r\n
              <strong>Wandercraft</strong>\r\n
              \r\n
              Wandercraft’s job is to let walking-impaired persons walk again. Wandercraft develops and commercializes the first autonomous walk exo. With this exo, persons with Spinal Cord Injury stood up and walked, with a realistic gait , autonomously and without crutches in world premiere clinical trials.\r\n
              \r\n
              Wandercraft’s team works on the edge of walk robotics, with the best academic labs in dynamic robotics and reputable medical teams, in Europe and the USA. The company plans to soon distribute its exos to rehabilitation centers and is developing a personal version. It received many prestigious awards and is supported by ambitious investors.\r\n
              \r\n
              Wandercraft makes real the promise of robotics to offer an ordinary life to extraordinary people.\r\n
              \r\n
              <em> Jean-Louis Constanza, Chief Business Officer - jean-louis.constanza@wandercraft.eu - <a href="http://www.wandercraft.eu">www.wandercraft.eu </a></em>\r\n
              \r\n
              <strong>About LBO France</strong>\r\n
              \r\n
              As a key player in private equity with €3.6bn of capital under management, LBO France is an independent company which has been supporting French companies in their growth for more than 30 years. Its strategy is based on 4 investment approaches in non-listed companies, managed by dedicated teams: (i) Mid Cap buyout via the White Knight funds and Small Cap buyout via the Hexagone funds, (ii) Venture Capital via the Innovation Capital funds, (iii) Real Estate via the White Stone and Lapillus funds, (iv) Debt. www.lbofrance.com\r\n
              \r\n
              SISA fund, dedicated to digital healthcare and autonomy, includes 9 investments : Voluntis, FittingBox, Zesty, Wandercraft, Biomodex, H4D, Kayentis, OpenHealth Company and BioSerenity.\r\n
              \r\n
              <strong>Contact :</strong> Valery Huot, Partner – Head of Innovation Capital - valery.huot@lbofrance.com\r\n
              \r\n
              <strong>Contact Presse</strong>: Citigate Dewe Rogerson - Robert Amady - +33 6 72 63 08 91 - robert.amady@citigate.fr / Daiana Hirte - +33 7 60 90 89 12 - daiana.hirte@citigate.fr\r\n
              \r\n
              <strong>About XAnge </strong>\r\n
              \r\n
              XAnge is a Franco-German Venture Capital team with €400m under management, investing in Software, Internet, Hard tech and Impact entrepreneurs. XAnge is part of Siparex, a leading French private equity group.\r\n
              \r\n
              <a href="http://www.XAnge.fr">www.XAnge.fr </a>\r\n
              \r\n
              <strong>About Idinvest Partners </strong>\r\n
              \r\n
              With more than €8 billion under management, Idinvest Partners is a leading pan-European private equity firm focused on the mid-market segment. Idinvest Partners has developed several complementary areas of expertise including: investments in innovative European startups; mid-market direct lending (unitranche, senior loans and junior financing); primary and secondary investments in unlisted European companies, and private equity consulting. Founded under the name AGF Private Equity in 1997, Idinvest Partners was formerly part of Allianz until 2010 when it became an independent firm.\r\n
              \r\n
              <a href="http://www.idinvest.com">www.idinvest.com</a>\r\n
              \r\n
              <strong>About Cemag Invest </strong>\r\n
              \r\n
              Cemag Invest is a family office created following the divestiture of the pharmaceutical company HRA. It focuses on early dev and cap dev minority investment in healthcare companies and BtoB services, always alongside institutional investors.\r\n
              \r\n
              Catherine Dunand, President - c.dunand@cemag-invest.com\r\n
              \r\n
              <strong>About Bpifrance</strong>\r\n
              \r\n
              Equity investment are operated by Bpifrance Investissement. Bpifrance, a subsidiary of the French state and the Caisse des Dépôts and the entrepreneurs’ trusted partner, finances businesses from the seed phase to IPO, through loans, guarantees and equity investments. Bpifrance also provides operational services and strong support for innovation, export, and external growth in parnertship with Business France. Bpifrance offers to businesses a large range of financing opportunities at each key step of their development, including offers adapted to regional specificities. With its 50 regional offices (90% of decisions are made locally) Bpifrance represents a strategic tool for economic competitiveness dedicated to entrepreneurs. Bpifrance acts as a back-up for initiatives driven by the French State and the Regions to tackle 3 goals:\r\n
              \r\n
              · Contributing to SME’s growth\r\n
              \r\n
              · Preparing tomorrow’s competitiveness\r\n
              \r\n
              · Contributing to the development of a positive entrepreneur ecosystem.\r\n
              \r\n
              With Bpifrance, businesses benefit from a powerful, efficient and close representative, to answer all their needs in terms of financing, innovation and investment.\r\n
              \r\n
              www.bpifrance.fr Twitter: @bpifrance / @bpifrancepresse\r\n
              \r\n
              Nicolas Jehly – nicolas.jehly@bpifrance.fr - 01 41 79 95 12\r\n
              \r\n
              &nbsp;\r\n
              \r\n
              &nbsp;\r\n
              \r\n
              <a href="https://preprod.lbofrance.com/wp-content/uploads/2019/12/wandercraft-pr-series-b-280917.pdf" target="_blank" rel="noopener noreferrer">Read Press Release</a>
              """
            +post_title: "Wandercraft raises 15m"
            +post_excerpt: ""
            +post_status: "publish"
            +comment_status: "open"
            +ping_status: "closed"
            +post_password: ""
            +post_name: "wandercraft-raises-15m"
            +to_ping: ""
            +pinged: ""
            +post_modified: "2020-02-11 15:10:32"
            +post_modified_gmt: "2020-02-11 14:10:32"
            +post_content_filtered: ""
            +post_parent: 0
            +guid: "http://preprod.lbofrance.com/wandercraft-leve-15-me/"
            +menu_order: 0
            +post_type: "post"
            +post_mime_type: ""
            +comment_count: "0"
            +filter: "raw"
            +"status": "publish"
            +"id": 2145
            +"slug": "wandercraft-raises-15m"
            +"custom": array:14 [
              "_wpml_media_featured" => "1"
              "_wpml_media_duplicate" => "1"
              "_yoast_wpseo_content_score" => "30"
              "banner" => ""
              "_banner" => "field_5d0b8f67a8a14"
              "linkedin" => ""
              "_linkedin" => "field_5d0b8fa0a8a15"
              "fichier" => ""
              "_fichier" => "field_5d0b8faba8a16"
              "_yoast_wpseo_primary_category" => ""
              "_edit_lock" => "1581430092:1"
              "_edit_last" => "1"
              "_wp_old_slug" => "wandercraft-leve-15-me"
              "_last_translation_edit_mode" => "native-editor"
            ]
          }
          4 => WP_Post {#7744
            +ID: 2146
            +post_author: "1"
            +post_date: "2017-09-20 09:08:28"
            +post_date_gmt: "2017-09-20 07:08:28"
            +post_content: """
              <strong>Paris, September 20th 2017 - Start-up specialized in connected solutions for patients, BioSerenity closed a Series A round of €15 million led by LBO France and investments from Idinvest Partners and PSIM fund managed by Bpifrance. </strong>\r\n
              \r\n
              BioSerenity has developed several product lines to facilitate the diagnosis and monitoring of patients. The high growth medtech company collaborated with several large scale university hospitals across the globe and plans on leveraging the new round of financing to continue its industrialization, and internationalization. With over 80 employees, BioSerenity has recently opened new offices in France, China and the United-States.\r\n
              \r\n
              BioSerenity offers disease specific full-stack solutions to speed up diagnosis, facilitate the follow-up and help calibrate treatments. The company currently focuses on 4 main pathological areas : Epilepsy, Cardiovascular diseases, Pregnancy monitoring and Sleep disorders.\r\n
              \r\n
              BioSerenity has successfully deployed a collaborative business model with the pharmaceutical industry through partnerships that rely on the creation of a complete technological solution (hardware device, smartphone app, medical cloud, and an automatic analysis of data by Artificial Intelligence). Each partnership is centered around a disease area in which the pharmaceutical company is specialized.\r\n
              \r\n
              The pharmaceutical companies use their global reach to deploy the solution around the world and take advantage of the devices for their own clinical trials or companion diagnostics strategy\r\n
              \r\n
              <img class="alignnone size-medium wp-image-3279" src="https://preprod.lbofrance.com/wp-content/uploads/2017/09/Capture-300x129.png" alt="" width="300" height="129" />\r\n
              \r\n
              <strong>Pierre Frouin, CEO and Founder of BioSerenity</strong> believes that the success of BioSerenity can be attributed to a combination of factors:<em> “A number of startups focus on a single technology block whereas BioSerenity has a solution based approach ranging from the capture of data to the analysis in a medical context, this makes us one of the only companies in our domain able to generate the expected medical gains. We have developed an important IP portfolio and we have a top-tier team that collaborates with a large ecosystem. BioSerenity was born in a hospital environment in the Brain and Spine Institute (icminstitute.org) and our pharmaceutical partners appreciate our deep understanding of clinical challenges”. For Pierre Frouin, “with this fund raising, we obtain not only the means to finance our growth but also investors who have expertise in the digital and medical innovation, two sectors that intersect at BioSerenity</em>”\r\n
              \r\n
              <strong> Valéry Huot, Partner and Head of Innovation Capital of LBO France</strong>, declares: <em>“We are glad to bring our support to BioSerenity and its management team. This is the 9th investment of our SISA fund dedicated to innovating companies focused on digital health in Europe. BioSerenity has an impressive track record and we are convinced that the company will continue its high growth. BioSerenity has all the assets to become a major player in bringing solutions for connected patients around the world.”</em>\r\n
              \r\n
              <strong> Emmanuel Audouard, Director of the PSIM fund at Bpifrance</strong>, adds : <em>“BioSerenity is one of the most promising MedTech companies in its domain. The company brings an innovative solution to diagnostics and monitoring problems. We are glad to support its growth by mobilizing our PSIM fund reserved for winners of the World Wide Innovation Challenge side by side with Idinvest Partners and LBO France.” </em>\r\n
              \r\n
              <strong>Luc Maruenda, Partner at Idinvest Partners</strong> concludes : <em>"BioSerenity has been executing brilliantly these last two years with the help of a team of 80 dynamic talents and academic, industrial and clinical partners of high quality. We are delighted to renew our trust in the management team of BioSerenity by reinvesting and welcoming new co-investors " </em>\r\n
              \r\n
              <strong>About Bioserenity </strong>\r\n
              \r\n
              BioSerenity, is a company created in 2014 and located inside the ICM Brain and Spine Institute (icm-institute.org) in La Pitié-Salpêtrière hospital, one of the largest and oldest hospitals in Europe. BioSerenity has a shared research lab with the ICM. With over 80 employees, BioSerenity quickly became one of the technology leaders in smart medical solutions for remote monitoring thanks to an integrated network of partners in the hospital, research and pharmaceutical industry.\r\n
              \r\n
              <a href="http://www.bioserenity.com">www.bioserenity.com</a>\r\n
              \r\n
              Contact : corporate@bioserenity.com - Téléphone : +33 1 84 25 64 27\r\n
              \r\n
              <strong> About Idinvest Partners</strong>\r\n
              \r\n
              The mission of Idinvest Partners, a European leader in financing small and medium-sized enterprises, is to fund European businesses at various stages of growth. With more than €8 billion under management, we can harness a range of complementary expertise to help businesses grow quickly using equity and private debt investment, both directly and via private equity funds. Since its formation in 1997, Idinvest has financed more than 3,500 European businesses through its three business lines: Venture &amp; Growth Capital, Private Debt and Private Funds Group.\r\n
              \r\n
              <a href="http://www.idinvest.com">www.idinvest.com </a>\r\n
              \r\n
              Contact : Luc Maruenda, Partner, lm@idinvest.com\r\n
              \r\n
              <strong>About LBO France</strong>\r\n
              \r\n
              As a key player in private equity with €3.6bn of capital under management, LBO France is an independent company which has been supporting French companies in their growth for more than 30 years. Its strategy is based on 4 investment approaches in non-listed companies, managed by dedicated teams: (i) Mid Cap buyout via the White Knight funds and Small Cap buyout via the Hexagone funds, (ii) Venture Capital via the Innovation Capital funds, (iii) Real Estate via the White Stone and Lapillus funds, (iv) Debt.\r\n
              \r\n
              <a href="http://www.lbofrance.com">www.lbofrance.com</a>\r\n
              \r\n
              BioSerenity is the 9th portfolio company of SISA fund, dedicated to digital healthcare and autonomy, following the investments in Voluntis, FittingBox, Zesty, Wandercraft, Biomodex, H4D, Kayentis and OpenHealth.\r\n
              \r\n
              Contact : Valery Huot, Partner – Head of Innovation Capital - valery.huot@lbofrance.com\r\n
              \r\n
              Press Contact : Citigate Dewe Rogerson - Robert Amady - - +33 6 72 63 08 91 - robert.amady@citigate.fr / Daiana Hirte - +33 7 60 90 89 12 - daiana.hirte@citigate.fr\r\n
              \r\n
              <strong>About Bpifrance</strong>\r\n
              \r\n
              Bpifrance, a subsidiary of Caisse des Dépôts and the French State, is a trusted partner of entrepreneurs which provides companies with credit, collateral and equity financing support - from start up through to stock exchange listing. In partnership with Business France, Bpifrance also provides guidance and enhanced support services for innovation, external growth, and exports. Bpifrance offers each company a range of financing for each key stage in its development, and an offer adapted to regional particularities. With 48 regional offices (90% of decisions are made regionally), Bpifrance offers entrepreneurs a tool for economic competitiveness. Bpifrance works in support of the public policies pursued nationally and regionally by the French government, to meet three objectives:\r\n
              \r\n
              • support the growth of businesses\r\n
              \r\n
              • prepare for future competitiveness\r\n
              \r\n
              • contribute to the development of an ecosystem that encourages entrepreneurship.\r\n
              \r\n
              With Bpifrance, companies benefit from a strong and effective local contact able to meet all their financial, innovation and investment needs.\r\n
              \r\n
              <a href="http://www.bpifrance.fr"> www.bpifrance.fr</a>\r\n
              \r\n
              Contact : Nicolas Jehly – nicolas.jehly@bpifrance.fr - +33 1 41 79 95 12\r\n
              \r\n
              &nbsp;\r\n
              \r\n
              &nbsp;\r\n
              \r\n
              <a href="https://preprod.lbofrance.com/wp-content/uploads/2019/12/en-pr-bioserenity-raises-eur15m-20092017.pdf" target="_blank" rel="noopener noreferrer">Read Press Release</a>
              """
            +post_title: "BioSerenity, digital health champion, raises 15m"
            +post_excerpt: ""
            +post_status: "publish"
            +comment_status: "open"
            +ping_status: "closed"
            +post_password: ""
            +post_name: "bioserenity-digital-health-champion-raises-15m"
            +to_ping: ""
            +pinged: ""
            +post_modified: "2020-02-11 15:10:43"
            +post_modified_gmt: "2020-02-11 14:10:43"
            +post_content_filtered: ""
            +post_parent: 0
            +guid: "http://preprod.lbofrance.com/bioserenity-champion-francais-de-la-e-sante-leve-15-me/"
            +menu_order: 0
            +post_type: "post"
            +post_mime_type: ""
            +comment_count: "0"
            +filter: "raw"
            +"status": "publish"
            +"id": 2146
            +"slug": "bioserenity-digital-health-champion-raises-15m"
            +"custom": array:16 [
              "_wpml_media_featured" => "1"
              "_wpml_media_duplicate" => "1"
              "_yoast_wpseo_content_score" => "30"
              "_wp_old_date" => "2019-12-18"
              "banner" => ""
              "_banner" => "field_5d0b8f67a8a14"
              "linkedin" => ""
              "_linkedin" => "field_5d0b8fa0a8a15"
              "fichier" => ""
              "_fichier" => "field_5d0b8faba8a16"
              "_yoast_wpseo_primary_category" => ""
              "_edit_lock" => "1581430109:1"
              "_edit_last" => "1"
              "_wp_old_slug" => "bioserenity-champion-francais-de-la-e-sante-leve-15-me"
              "_last_translation_edit_mode" => "native-editor"
              "_wpml_media_has_media" => "1"
            ]
          }
          5 => WP_Post {#7745
            +ID: 2147
            +post_author: "1"
            +post_date: "2017-09-13 09:13:24"
            +post_date_gmt: "2017-09-13 07:13:24"
            +post_content: """
              <strong>Paris, 13th September 2017 – OpenHealth Company, specialised in real-time healthcare data collection and analysis, closed a financing round over €5m led by LBO France / Innovation Capital. In September, it will launch The Hub, the largest healthcare data analysis platform available in France.</strong>\r\n
              \r\n
              OpenHealth’s Hub aggregates data from multiple sources to offer a variety of powerful capabilities for analysis in three major areas:\r\n
              \r\n
              - Sales and marketing: Consumer data on all types of healthcare products (more than 200,000 referenced) aimed at the pharmaceutical industry and marketing research firms. These data are available in real time and include sales in pharmacies and supermarkets thanks to a partnership with IRI.\r\n
              \r\n
              - Health watch: Analysis and mapping by geographical area to conduct epidemiological analyses, monitor healthcare product sales and track health events in real time.\r\n
              \r\n
              - Safe use of healthcare products: The analysis of proper medication use and the creation of online cohorts provide information about how medicines and healthcare products are used in real-life (age of patients treated, related treatments, compliance with contraindications and good practices, treatment regimens, etc.), which is essential for risk management by manufacturers and health authorities.\r\n
              \r\n
              These new services will make it possible for data to be explored and analysed through a simple web browser, thereby giving all stakeholders, healthcare industries, public authorities, consulting firms and research organisations easy access to relevant data.\r\n
              \r\n
              The analysis of healthcare data will gradually change how we understand various challenges in the healthcare sector. After massive investments in many developed countries, and especially North America, this was the first fundraising operation to be held in France in this field. Through its SISA fund dedicated to companies in the European digital healthcare sector, LBO France / Innovation Capital led the round over €5m. In 2017, OpenHealth Company also received financial support from Bpifrance.\r\n
              \r\n
              <em> “By making data more accessible to stakeholders and allowing them to develop indicators that were previously complex and costly to obtain, we are accelerating the production of new knowledge”, says Dr Patrick Guérin, President of OpenHealth. “Either for market studies, post-authorisation studies on health product use or healthcare safety, OpenHealth’s Hub is helping to make deep changes to how we understand these data while maintaining the strictest level of privacy”</em>, explains <strong>CEO Dr Jean-Yves Robin.</strong>\r\n
              \r\n
              Ingrid Rayez, Director of Investment at LBO France / Innovation Capital, adds, “We are thrilled to work with OpenHealth and its experienced leaders. This is the eighth investment of our SISA fund dedicated to digital healthcare and autonomy in Europe. The collection and real-time analysis of healthcare data has become key, especially for monitoring the use of healthcare products in real world. With The Hub, OpenHealth is well positioned to become leader in this sector.”\r\n
              \r\n
              Contacts: For OpenHealth:\r\n
              \r\n
              Contact:\r\n
              \r\n
              Catherine Commaille-Chapus - +33 2 97 68 37 00 - c.commaille-chapus@openhealth.fr\r\n
              \r\n
              Press contact: LauMa communication\r\n
              \r\n
              Laurie Marcellesi - +33 1 73 03 05 20 - laurie.marcellesi@lauma-communication.com\r\n
              \r\n
              For LBO France / Innovation Capital:\r\n
              \r\n
              Contact:\r\n
              \r\n
              Ingrid Rayez - +33 1 80 06 99 15 - ingrid.rayez@lbofrance.com\r\n
              \r\n
              Press contact: Citigate Dewe Rogerson\r\n
              \r\n
              Robert Amady - +33 1 53 32 78 91 - +33 6 72 63 08 91 - robert.amady@citigate.fr\r\n
              \r\n
              Daiana Hirte - +33 1 53 32 78 90 - +33 7 60 90 89 12 - daiana.hirte@citigate.fr\r\n
              \r\n
              <strong> About OpenHealth</strong>\r\n
              \r\n
              OpenHealth Company, founded in 2015 by Patrick Guérin, former President of Celtipharm, and JeanYves Robin, former Director of ASIP Santé, is the leading French company in the collection and realtime analysis of healthcare data. This expertise is supported by the processing of multiple data sources, including pharmacy sales data (a panel of more than 10,000 pharmacies, retained by the French High Authority of Health – HAS and the National Agency for the Safety of Medicine and Health Products – ANSM), geographical data, longitudinal patient data, outpatient medical data and international data. The company provides industrial and institutional customers with new flexible solutions and unique sector-specific support with its multidisciplinary team of doctors, pharmacists, statisticians, market access experts and industry executives. OpenHealth, which has around 50 employees at its Parisian headquarters and production site in Vannes, France, has projected its 2017 turnover at around €10m. The company is an accredited personal healthcare data host.\r\n
              \r\n
              For more information, go to <a href="http://www.openhealth.fr.">www.openhealth.fr. </a>\r\n
              \r\n
              <strong>About LBO France / Innovation Capital</strong>\r\n
              \r\n
              As a key player in private equity with €3.6bn of capital under management, LBO France is an independent company which has been supporting French companies in their growth for more than 30 years. Its strategy is based on four investment approaches in non-listed companies, managed by dedicated teams: (i) Mid Cap buyout via the White Knight funds and Small Cap buyout via the Hexagone funds, (ii) Venture Capital via the Innovation Capital funds, (iii) Real Estate via the White Stone and Lapillus funds, (iv) Debt. The SISA fund, Innovation Capital’s latest fund dedicated to digital healthcare and autonomy, is today strong of 8 portfolio companies : Voluntis, FittingBox, Zesty, Wandercraft, Biomodex, H4D, Kayentis and OpenHealth.\r\n
              \r\n
              &nbsp;\r\n
              \r\n
              &nbsp;\r\n
              \r\n
              <a href="https://preprod.lbofrance.com/wp-content/uploads/2019/12/lbo-france-innovation-capital-pr-openhealth-company-13092017.pdf" target="_blank" rel="noopener noreferrer">Read Press Release</a>
              """
            +post_title: "OpenHealth Company, the 8th investment of SISA fund managed by LBO France / Innovation Capital"
            +post_excerpt: ""
            +post_status: "publish"
            +comment_status: "open"
            +ping_status: "closed"
            +post_password: ""
            +post_name: "openhealth-company-the-8th-investment-of-sisa-fund-managed-by-lbo-france-innovation-capital"
            +to_ping: ""
            +pinged: ""
            +post_modified: "2020-02-11 15:10:52"
            +post_modified_gmt: "2020-02-11 14:10:52"
            +post_content_filtered: ""
            +post_parent: 0
            +guid: "http://preprod.lbofrance.com/openhealth-company-le-8eme-investissement-du-fonds-sisa-gere-par-lbo-france-innovation-capital/"
            +menu_order: 0
            +post_type: "post"
            +post_mime_type: ""
            +comment_count: "0"
            +filter: "raw"
            +"status": "publish"
            +"id": 2147
            +"slug": "openhealth-company-the-8th-investment-of-sisa-fund-managed-by-lbo-france-innovation-capital"
            +"custom": array:16 [
              "_yoast_wpseo_content_score" => "30"
              "_wp_old_date" => "2019-12-18"
              "banner" => ""
              "_banner" => "field_5d0b8f67a8a14"
              "linkedin" => ""
              "_linkedin" => "field_5d0b8fa0a8a15"
              "fichier" => ""
              "_fichier" => "field_5d0b8faba8a16"
              "_yoast_wpseo_primary_category" => "70"
              "_wpml_media_duplicate" => "1"
              "_wpml_media_featured" => "1"
              "_edit_lock" => "1581430113:1"
              "_edit_last" => "1"
              "_wp_old_slug" => "openhealth-company-le-8eme-investissement-du-fonds-sisa-gere-par-lbo-france-innovation-capital"
              "_last_translation_edit_mode" => "native-editor"
              "_wpml_media_has_media" => "1"
            ]
          }
          6 => WP_Post {#7747
            +ID: 2149
            +post_author: "1"
            +post_date: "2017-09-04 09:16:44"
            +post_date_gmt: "2017-09-04 07:16:44"
            +post_content: """
              <strong>Paris, September 4, 2017</strong> – LBO France announced the acquisition of a majority stake in PIEX (“the Company”). This buy-out operation is led partnering with Mr. Bertrand Talbotier and the Company’s management team, as well as funds AfricInvest Europe, BNP Paribas Développement, BPI and Trocadéro Capital Partners.\r\n
              \r\n
              PIEX is a specialized distribution company which was founded in 1979 by Mr. Robert Jamain, incumbent CEO, and which, over the past years, grew to become a key player in the distribution of pharmaceutical and parapharmaceutical products in French-speaking Sub-Saharan Africa.\r\n
              \r\n
              Its unique positioning, based upon its strong expertise of targeted markets and ability to handle products from many pharmaceutical and parapharmaceutical companies in a professional, agile and flexible way, positions PIEX as an indispensable and trusted partner of groups to enter the African market through a wide network of local wholesalers.\r\n
              \r\n
              Thanks to its proven know-how and tailor-made logistics, the Company has, over the past 40 years, secured privileged relationships with its historical clients, worldwide’s pharmaceutical groups and health professionals which mainly operate in Sub-Saharan Africa, and in Central Asia from now on.\r\n
              \r\n
              PIEX has recorded an average annual growth (CAGR) in its revenue of ca. 12% since 2005 and has reached €80 million in revenue in 2016, spread over more than 30 countries, including Ivory Coast (22%), Senegal (14%) and Cameroon (10%).\r\n
              \r\n
              The Company distributes more than 750 products to ca. 350 clients.\r\n
              \r\n
              In order to increase PIEX’s revenue and market shares, LBO France has teamed up with a new management team, led by Bertrand Talbotier (seasoned entrepreneur with more than 20-year experience in the pharmaceutical industry and a strong knowledge of the African market), and identified 3 main priorities:\r\n
              \r\n
              - Further develop its client base to include new pharmaceutical groups and biotech companies;\r\n
              \r\n
              - Expand its business activities into new high-growth geographical markets;\r\n
              \r\n
              - Broaden its offer of high value-added services.\r\n
              \r\n
              <strong>Jean-Marie Leroy, Partner at LBO France</strong>, commented: <em>"This primary LBO perfectly illustrates our strategy of accompanying family-owned companies in their new development phase and led by a new management team. This acquisition is a meaningful choice made by LBO France in its investment options and the very nature of PIEX, a company operating in the heath sector and mainly towards the African market, demonstrates our commitment to the ESG principles guiding our investment approach." </em>\r\n
              \r\n
              <strong>Bertrand Talbotier, PIEX’s newly appointed CEO</strong>, added:<em> "PIEX’s acquisition by LBO France and its management team is a key milestone in the implementation of our defined strategy which aims at creating a leading player in the distribution of pharmaceutical products. Our conviction for PIEX is to improve patients’ life and health in targeted geographical areas and bring high quality genuine products and services within reach to historically disadvantaged people and countries. Our ambition is to build a model which is known for being innovative, profitable, long-lasting, respectful and exemplary in its operational roll-out. I am very honored to be given the opportunity to lead this ambitious project, alongside LBO France and our partners, towards achieving the expected success." </em>\r\n
              \r\n
              Parties involved:\r\n
              \r\n
              LBO France\r\n
              \r\n
              - LBO France Team: Jean-Marie Leroy, Partner Small Cap\r\n
              \r\n
              LBO France Emmanuel Fiorentino, Investment Manager\r\n
              \r\n
              Karine Callec, General Counsel\r\n
              \r\n
              - Finance: Grant Thornton : Emmanuel Riou\r\n
              \r\n
              Anissa Ghaouti\r\n
              \r\n
              - Legal: Jeantet : Philippe Matignon\r\n
              \r\n
              Pascal Georges\r\n
              \r\n
              Nicolas Goetz\r\n
              \r\n
              Gabriel di Chiara\r\n
              \r\n
              Camille Perodeau\r\n
              \r\n
              - Strategy : Alcimed : Vincent Genet\r\n
              \r\n
              Loïc Marce\r\n
              \r\n
              - HR : Cabinet Bilanciel\r\n
              \r\n
              Sophie Touttée Henrotte\r\n
              \r\n
              - - -\r\n
              \r\n
              <strong>About LBO France </strong>\r\n
              \r\n
              As a key player in private equity with €3.6bn of capital under management, LBO France is an independent company that has been supporting French companies in their growth for more than 30 years. Its strategy is based on 4 investment approaches in non-listed assets, managed by dedicated teams: (i) Mid Cap buyout through the White Knight funds and Small Cap buyout through the Hexagone funds, (ii) Innovation-Capital through the Innovation Capital funds, (iii) Real Estate through the White Stone and Lapillus funds, (iv) Debt. LBO France is 100%-owned by its management and employs almost 60 professionals.\r\n
              \r\n
              <a href="http://www.lbofrance.com">www.lbofrance.com </a>\r\n
              \r\n
              <strong>Media Contacts For LBO France</strong> - Citigate Dewe Rogerson\r\n
              \r\n
              Robert Amady - +33 1 53 32 78 91 - +33 6 72 63 08 91 - robert.amady@citigate.fr\r\n
              \r\n
              Daiana Hirte - +33 1 53 32 78 90 - +33 7 60 90 89 12 - daiana.hirte@citigate.fr\r\n
              \r\n
              &nbsp;\r\n
              \r\n
              &nbsp;\r\n
              \r\n
              <a href="https://preprod.lbofrance.com/wp-content/uploads/2019/12/170904-lbo-france-acq-piex-press-release-final.pdf" target="_blank" rel="noopener noreferrer">Read Press Release</a>
              """
            +post_title: "LBO France announced the acquisition of PIEX"
            +post_excerpt: ""
            +post_status: "publish"
            +comment_status: "open"
            +ping_status: "closed"
            +post_password: ""
            +post_name: "lbo-france-announced-the-acquisition-of-piex-2"
            +to_ping: ""
            +pinged: ""
            +post_modified: "2020-02-11 15:11:21"
            +post_modified_gmt: "2020-02-11 14:11:21"
            +post_content_filtered: ""
            +post_parent: 0
            +guid: "http://preprod.lbofrance.com/lbo-france-annonce-lacquisition-de-la-societe-piex/"
            +menu_order: 0
            +post_type: "post"
            +post_mime_type: ""
            +comment_count: "0"
            +filter: "raw"
            +"status": "publish"
            +"id": 2149
            +"slug": "lbo-france-announced-the-acquisition-of-piex-2"
            +"custom": array:16 [
              "_wpml_media_featured" => "1"
              "_wpml_media_duplicate" => "1"
              "_yoast_wpseo_content_score" => "30"
              "_wp_old_date" => "2019-12-18"
              "banner" => ""
              "_banner" => "field_5d0b8f67a8a14"
              "linkedin" => ""
              "_linkedin" => "field_5d0b8fa0a8a15"
              "fichier" => ""
              "_fichier" => "field_5d0b8faba8a16"
              "_yoast_wpseo_primary_category" => ""
              "_edit_lock" => "1581430282:1"
              "_edit_last" => "1"
              "_wp_old_slug" => "lbo-france-annonce-lacquisition-de-la-societe-piex"
              "_last_translation_edit_mode" => "native-editor"
              "_wpml_media_has_media" => "1"
            ]
          }
          7 => WP_Post {#7736
            +ID: 2150
            +post_author: "1"
            +post_date: "2017-07-27 09:17:39"
            +post_date_gmt: "2017-07-27 07:17:39"
            +post_content: """
              <strong>Paris, 27 July 2017</strong> – LBO France announced the acquisition of a majority stake in SERAPID (“the company”). This buy-out operation is led partnering with two managers, Emeric Labesse and Guillaume Davies, as well as the historic shareholder Saïd Lounis.\r\n
              \r\n
              SERAPID is a French company created in 1972. As the creator of the rigid chain technology, SERAPID designs and manufactures telescopic mechanical links used for the horizontal and vertical displacement of heavy loads and the rapid change of press tools. Thanks to its intrinsic advantages (clean, reliable and compact technology), the rigid chain is a real alternative to traditional mechanical and hydraulic solutions that meet the needs of various industries (automotive, nuclear, aerospace, medical and entertainment).\r\n
              \r\n
              Building on its success, the company reached €26m of sales in 2016, of which 70% in industrial equipment and 30% in scenic and architectural.\r\n
              \r\n
              Headquartered in Dieppe, the company already has a very strong international presence, with 59% of its revenues generated in Europe, 37% in North America and 4% in Asia. The company employs 116 employees.\r\n
              \r\n
              In order to accelerate its development in the coming years, SERAPID has identified three major axes:\r\n
              \r\n
              - Accelerating the international deployment of historical applications;\r\n
              \r\n
              - Deployment of new applications in the medical, defense and lift markets for freight, trucks and cars;\r\n
              \r\n
              - Strengthening the existing organization.\r\n
              \r\n
              <strong>Jean-Marie Leroy, Partner at LBO France</strong>, commented: <em>« This primary LBO, negotiated off-market in the frame of a proprietary transaction, illustrates our small cap strategy perfectly. We support French companies willing to expand abroad. » </em>\r\n
              \r\n
              Parties involved:\r\n
              \r\n
              LBO France\r\n
              \r\n
              - LBO France team : Jean-Marie Leroy, Partner Small Cap LBO France\r\n
              \r\n
              Louis de Lummen, Investment Manager\r\n
              \r\n
              Karine Callec, General Counsel\r\n
              \r\n
              - Finance : EY : Jean-François Nadaud\r\n
              \r\n
              Guilhem de Montmarin\r\n
              \r\n
              - Legal : Jeantet : Philippe Matignon\r\n
              \r\n
              Pascal Georges\r\n
              \r\n
              - Strategic : LEK : Serge Hosepian\r\n
              \r\n
              Maxime Julian\r\n
              \r\n
              - - -\r\n
              \r\n
              <strong>About LBO France</strong>\r\n
              \r\n
              As a key player in private equity with €3.6bn of capital under management, LBO France is an independent company that has been supporting French companies in their growth for more than 30 years. Its strategy is based on 4 investment approaches in non-listed assets, managed by dedicated teams: (i) Mid Cap buyout through the White Knight funds and Small Cap buyout through the Hexagone funds, (ii) Innovation-Capital through the Innovation Capital funds, (iii) Real Estate through the White Stone and Lapillus funds, (iv) Debt. LBO France is 100%-owned by its management and employs almost 60 professionals.\r\n
              \r\n
              <a href="http://www.lbofrance.com">www.lbofrance.com </a>\r\n
              \r\n
              Press Contacts For LBO France - Citigate Dewe Rogerson\r\n
              \r\n
              Robert Amady - +33 1 53 32 78 91 - +33 6 72 63 08 91 - robert.amady@citigate.fr Daiana Hirte - +33 1 53 32 78 90 - +33 7 60 90 89 12 - daiana.hirte@citigate.fr\r\n
              \r\n
              &nbsp;\r\n
              \r\n
              &nbsp;\r\n
              \r\n
              <a href="https://preprod.lbofrance.com/wp-content/uploads/2019/12/170727-lbo-france-acq-serapid-pr-final.pdf" target="_blank" rel="noopener noreferrer">Read Press Release</a>
              """
            +post_title: "LBO France announced the acquisition of SERAPID"
            +post_excerpt: ""
            +post_status: "publish"
            +comment_status: "open"
            +ping_status: "closed"
            +post_password: ""
            +post_name: "lbo-france-announced-the-acquisition-of-serapid"
            +to_ping: ""
            +pinged: ""
            +post_modified: "2020-02-04 18:56:24"
            +post_modified_gmt: "2020-02-04 17:56:24"
            +post_content_filtered: ""
            +post_parent: 0
            +guid: "http://preprod.lbofrance.com/lbo-france-annonce-lacquisition-de-la-societe-serapid/"
            +menu_order: 0
            +post_type: "post"
            +post_mime_type: ""
            +comment_count: "0"
            +filter: "raw"
            +"status": "publish"
            +"id": 2150
            +"slug": "lbo-france-announced-the-acquisition-of-serapid"
            +"custom": array:15 [
              "_wpml_media_featured" => "1"
              "_wpml_media_duplicate" => "1"
              "_yoast_wpseo_content_score" => "60"
              "_wp_old_date" => "2019-12-18"
              "banner" => ""
              "_banner" => "field_5d0b8f67a8a14"
              "linkedin" => ""
              "_linkedin" => "field_5d0b8fa0a8a15"
              "fichier" => ""
              "_fichier" => "field_5d0b8faba8a16"
              "_yoast_wpseo_primary_category" => ""
              "_edit_lock" => "1581430145:1"
              "_edit_last" => "1"
              "_wp_old_slug" => "lbo-france-annonce-lacquisition-de-la-societe-serapid"
              "_last_translation_edit_mode" => "native-editor"
            ]
          }
          8 => WP_Post {#7870
            +ID: 2152
            +post_author: "1"
            +post_date: "2017-07-26 09:27:43"
            +post_date_gmt: "2017-07-26 07:27:43"
            +post_content: """
              <strong>Paris, 26 July 2017</strong> – LBO France and Abenex announced today that they have signed an exclusive agreement aiming at the acquisition by LBO France of the majority stake in RG Safety Group (“the Group”) currently held by Abenex.\r\n
              \r\n
              Founded in 1987, headquartered in Saint Priest, and now managed by Pierre Manchini (CEO), RG Safety Group is the French leading specialized distributor of Personal Protective Equipment (PPE). The group distributes a wide range of products (35,000 references) covering 6 main protection fields: Head, Hand, Foot, Body, Breathing, and Hygiene &amp; Safety in the working environment. The Group is also successfully selling products under its own brand, Ergos, which today accounts for ca. 30% of total sales. Main clients comprise of large corporations, SMEs from the industry and service sectors and public sector entities.\r\n
              \r\n
              Operating through 27 branches (of which 20 in France), the Group employs 430 employees. In 2016, RG Safety Group saw sales growing by 17% to reach over €180M, notably further to the acquisition of Italian A+A Monferrato. International (outside France) sales now account for ca. 20% of total sales.\r\n
              \r\n
              To spur growth, RG Safety Group intends to rely on both organic and external growth to create the European leader within the PPE market by 2022, driven by:\r\n
              \r\n
              - consolidating the French PPE distribution market (market share gains, development on new segments and multi-channel offering);\r\n
              \r\n
              - expanding commercial operations in Europe with a more direct access to local clients and assistance to international clients;\r\n
              \r\n
              - integrating acquisition targets, primarily in Europe.\r\n
              \r\n
              The transaction remains subject to consultations with employee representative bodies and approval by relevant competition authorities.\r\n
              \r\n
              <strong>Jérôme Guez, Partner at LBO France</strong>, commented: <em>"We would be pleased to partner with Pierre Manchini and his teams to support RG Safety Group in its continued growth and innovation capacity, enabling it to become one of Europe’s leading distributors of Personal Protective Equipment." </em>\r\n
              \r\n
              <em>"We are very excited about the possibility to enter in a new partnership with LBO France to continue to execute the strategic plan we have initiated 3 years from now, and together, accelerate, organically and through targeted acquisitions, RG Safety Group’s growth trajectory and geographic expansion in Europe."</em> added <strong>Pierre Manchini, CEO of RG Safety Group</strong>.\r\n
              \r\n
              <strong>Johann Dupont, Partner in charge of Operating team at Abenex</strong> said: <em>"Abenex is proud to have supported the growth and development of RG Safety Group during these past 4 years, paving the way for a true European leadership." </em>\r\n
              \r\n
              Parties involved:\r\n
              \r\n
              LBO France\r\n
              \r\n
              - LBO France team: Jérôme Guez, Simon Couturier LBO Mid cap White Knight, and Gilles Taldu, Head of the Operating team\r\n
              \r\n
              - Finance : Deloitte : Frédérique Chenevoy\r\n
              \r\n
              - Legal: Mayor-Brown : Emily Pennec, Xavier Jaspar and Laurent Borey\r\n
              \r\n
              - Strategic : Advention : Alban Neveux\r\n
              \r\n
              Abenex\r\n
              \r\n
              - Abenex team: Johann Dupont and Matthieu Balaÿ\r\n
              \r\n
              - M&amp;A : Rothschild &amp; Cie (Transaction R) :\r\n
              \r\n
              o M&amp;A : Pierre Sader, Benjamin Osdoit, Guillaume Marquet de Vasselot, Cyril Petit\r\n
              \r\n
              o Financing : Mathilde Paoli\r\n
              \r\n
              - Legal : DLA Piper : Michel Frieh, Matthieu Lampel, Anaïs Vidal\r\n
              \r\n
              - Vendor Due Diligence :\r\n
              \r\n
              o Finance : Deloitte : Eric Boucharlat, Thomas Gorguis, Kevin Profit and Noémie Picaud\r\n
              \r\n
              o Legal, Social, Tax: DLA Piper : Michel Frieh, Matthieu Lampel, Anaïs Vidal, Jérôme Halphen, Eva Amor, Guillaume Valois, Emilie Renaud ;\r\n
              \r\n
              o Strategic: Indefi : Julien Berger, Charles-Antoine Dreyfus Management\r\n
              \r\n
              - Finance : Canacord : Nadim Barouki\r\n
              \r\n
              - Legal: Delaby : Emmanuel Delaby\r\n
              \r\n
              - - -\r\n
              \r\n
              <strong>About LBO France </strong>\r\n
              \r\n
              As a key player in private equity with €3.6bn of capital under management, LBO France is an independent company that has been supporting French companies in their growth for more than 30 years. Its strategy is based on 4 investment approaches in non-listed assets, managed by dedicated teams: (i) Mid Cap buyout through the White Knight funds and Small Cap buyout through the Hexagone funds, (ii) Innovation-Capital through the Innovation Capital funds, (iii) Real Estate through the White Stone and Lapillus funds, (iv) Debt. LBO France is 100%-owned by its management and employs almost 60 professionals.\r\n
              \r\n
              <a href="http://www.lbofrance.com">www.lbofrance.com</a>\r\n
              \r\n
              <strong>About RG Safety Group</strong>\r\n
              \r\n
              With more than €180 million in revenue, RG Safety Group operates through 27 branches in France and in Europe with ca. 430 employees and serves 40,000 active clients.\r\n
              \r\n
              RG Safety’s Group products cover 6 main protection fields:\r\n
              \r\n
              • Head protection (hardhats and ear defenders, goggles)\r\n
              \r\n
              • Breathing protection (masks, respirators…)\r\n
              \r\n
              • Hand protection (tear/heat/chemical resistant gloves…)\r\n
              \r\n
              • Body protection (professional, safety and short use clothing)\r\n
              \r\n
              • Foot protection (safety shoes)\r\n
              \r\n
              • Safety and hygiene (consignment and safety of the work environment…)\r\n
              \r\n
              RG Safey Group is also known through the following brand names: FIPROTEC, GERIN, AMIET, CEVENOLE DE PROTECTION in France, A+A MONFERRATO in Italy, KNOLL ARBEITSSCHUTZ in Germany, LISAP in Belgium, RG SAFETY IBERICA in Spain, RG SWISS in Switzerland, MIDITECH in Slovakia et RG Tunisia in Tunisia.\r\n
              \r\n
              <a href="http://www.groupe-rg.com">www.groupe-rg.com </a>\r\n
              \r\n
              <strong>About Abenex</strong>\r\n
              \r\n
              Abénex is a fully independent private equity firm. Abénex makes long term investments alongside managers in high growth and operational improvement transactions. Abénex specialises in capital development and buy-outs with or without financial leverage. With a strong focus on corporate strategy, operational excellence, and financial performance, Abénex leverages its network, resources and experience to help build value for customers, employees, and shareholders. The team benefits from a proven know-how in external growth projects, public-toprivate transactions, and in partnering with family owners. Abénex invests in companies valued up to €300m, either through majority or minority stakes. www.abenexcapital.com\r\n
              \r\n
              <strong>Press Contacts For LBO France</strong> - Citigate Dewe Rogerson\r\n
              \r\n
              Robert Amady - +33 1 53 32 78 91 - +33 6 72 63 08 91 - robert.amady@citigate.fr\r\n
              \r\n
              Daiana Hirte - +33 1 53 32 78 90 - +33 7 60 90 89 12 - daiana.hirte@citigate.fr\r\n
              \r\n
              <strong>For RG Safety Group </strong>\r\n
              \r\n
              Marie Patricio - +33 4 72 23 24 40 – mpatricio@groupe-rg.com\r\n
              \r\n
              <strong>For Abenex </strong>\r\n
              \r\n
              Johann Dupont - +33 1 53 93 69 04 - +33 6 23 38 46 46 - johann.dupont@abenex.com\r\n
              \r\n
              &nbsp;\r\n
              \r\n
              &nbsp;\r\n
              \r\n
              <a href="https://preprod.lbofrance.com/wp-content/uploads/2019/12/170726-lbo-france-acq-rg-safety-pr-final.pdf" target="_blank" rel="noopener noreferrer">Read Press Release</a>
              """
            +post_title: "LBO France enters into exclusive negotiations with Abenex for the acquisition of RG Safety Group"
            +post_excerpt: ""
            +post_status: "publish"
            +comment_status: "open"
            +ping_status: "closed"
            +post_password: ""
            +post_name: "lbo-france-enters-into-exclusive-negotiations-with-abenex-for-the-acquisition-of-rg-safety-group"
            +to_ping: ""
            +pinged: ""
            +post_modified: "2020-02-04 19:04:24"
            +post_modified_gmt: "2020-02-04 18:04:24"
            +post_content_filtered: ""
            +post_parent: 0
            +guid: "http://preprod.lbofrance.com/lbo-france-entre-en-negociations-exclusives-avec-abenex-pour-la-reprise-du-groupe-rg-safety/"
            +menu_order: 0
            +post_type: "post"
            +post_mime_type: ""
            +comment_count: "0"
            +filter: "raw"
            +"status": "publish"
            +"id": 2152
            +"slug": "lbo-france-enters-into-exclusive-negotiations-with-abenex-for-the-acquisition-of-rg-safety-group"
            +"custom": array:16 [
              "_wpml_media_featured" => "1"
              "_wpml_media_duplicate" => "1"
              "_yoast_wpseo_content_score" => "30"
              "_wp_old_date" => "2019-12-18"
              "banner" => ""
              "_banner" => "field_5d0b8f67a8a14"
              "linkedin" => ""
              "_linkedin" => "field_5d0b8fa0a8a15"
              "fichier" => ""
              "_fichier" => "field_5d0b8faba8a16"
              "_yoast_wpseo_primary_category" => ""
              "_edit_lock" => "1581430164:1"
              "_edit_last" => "1"
              "_wp_old_slug" => array:2 [
                0 => "lbo-france-entre-en-negociations-exclusives-avec-abenex-pour-la-reprise-du-groupe-rg-safety"
                1 => "lbo-france-enters-into-exclusive-negotiations-with-cinven-for-the-sale-of-chryso"
              ]
              "_last_translation_edit_mode" => "native-editor"
              "_wpml_media_has_media" => "1"
            ]
          }
        ]
        +post_count: 9
        +current_post: -1
        +before_loop: true
        +in_the_loop: false
        +post: WP_Post {#7741}
        +comment_count: 0
        +current_comment: -1
        +found_posts: 91
        +max_num_pages: 11
        +max_num_comment_pages: 0
        +is_single: false
        +is_preview: false
        +is_page: false
        +is_archive: false
        +is_date: false
        +is_year: false
        +is_month: false
        +is_day: false
        +is_time: false
        +is_author: false
        +is_category: false
        +is_tag: false
        +is_tax: false
        +is_search: false
        +is_feed: false
        +is_comment_feed: false
        +is_trackback: false
        +is_home: true
        +is_privacy_policy: false
        +is_404: false
        +is_embed: false
        +is_paged: true
        +is_admin: false
        +is_attachment: false
        +is_singular: false
        +is_robots: false
        +is_favicon: false
        +is_posts_page: true
        +is_post_type_archive: false
        -query_vars_hash: "9e92d8a1ffec457f0fbd1d3a7dc1f515"
        -query_vars_changed: true
        +thumbnails_cached: false
        #allow_query_attachment_by_filename: false
        -stopwords: null
        -compat_fields: array:2 [
          0 => "query_vars_hash"
          1 => "query_vars_changed"
        ]
        -compat_methods: array:2 [
          0 => "init_query_flags"
          1 => "parse_tax_query"
        ]
      }
      -_posts_class: "\Timber\Post"
    }
    #pagination: null
    flag::STD_PROP_LIST: false
    flag::ARRAY_AS_PROPS: false
    iteratorClass: "Timber\PostsIterator"
    storage: array:9 [
      0 => Post {#432
        +ImageClass: "Timber\Image"
        +PostClass: "Timber\Post"
        +TermClass: "Timber\Term"
        +object_type: "post"
        +custom: array:16 [
          "_wpml_media_featured" => "1"
          "_wpml_media_duplicate" => "1"
          "_yoast_wpseo_content_score" => "30"
          "_wp_old_date" => "2019-12-18"
          "banner" => ""
          "_banner" => "field_5d0b8f67a8a14"
          "linkedin" => ""
          "_linkedin" => "field_5d0b8fa0a8a15"
          "fichier" => ""
          "_fichier" => "field_5d0b8faba8a16"
          "_yoast_wpseo_primary_category" => ""
          "_edit_lock" => "1581430034:1"
          "_edit_last" => "1"
          "_wp_old_slug" => "lbo-france-signe-un-accord-final-pour-lacquisition-de-crouzet"
          "_last_translation_edit_mode" => "native-editor"
          "_wpml_media_has_media" => "1"
        ]
        #___content: null
        #_permalink: null
        #_next: []
        #_prev: []
        #_css_class: null
        +id: 2142
        +ID: 2142
        +post_author: "1"
        +post_content: """
          <strong>Paris, on December 13th 2017</strong> – LBO France announces today that it has entered into a definitive agreement for the acquisition of Crouzet (the “Company”), a worldwide leader specialized in customized switches, electric actuators and automated systems for critical applications, from InnoVista Sensors, a company owned by PAI Partners, The Carlyle Group and Schneider Electric. The transaction has already received a favorable opinion from the relevant works council and remains subject to customary regulatory approvals. The transaction is expected to close by early 2018.\r\n
          \r\n
          Founded in 1921 and today comprising approximately 1,200 employees, the Company serves diversified end-markets, including aerospace &amp; industry, transportation, energy &amp; infrastructure and other industries, through 3 principal production sites (France, Morocco and China). In 2016, Crouzet generated €136 million in sales, 74% of which outside France.\r\n
          \r\n
          As a result of its technical expertise and longstanding industrial history, Crouzet has gained strong recognition of leadership over the years and secured privileged relationships with its clients.\r\n
          \r\n
          In addition, the Company’s client base is highly diversified with more than 1,000 active customers.\r\n
          \r\n
          <strong>Thomas Boulman, Partner at LBO France</strong>, commented: <em>"This investment in Crouzet illustrates LBO France’s strategy of partnering with leaders in attractive niche sectors with recognized technological expertise customization capabilities, critical applications supplying and international geographical coverage. We have been impressed and comforted by the work done in the past years by the management under the joint ownership of PAI Partners, The Carlyle Group and Schneider Electric. We are now excited to team up with the management to support the Company on its new development phase and are eager to accelerate Crouzet’s ambitious strategy of product and technological innovation, market and geography deployment as well as selected build-up acquisitions." </em>\r\n
          \r\n
          <strong>David Arragon, CEO of Crouzet</strong>, added: <em>"With the support of LBO France as its new shareholder, we are confident on Crouzet’s capacity to carry on its development strategy and to consolidate its worldwide leadership on its niche markets.</em>"\r\n
          \r\n
          LBO France (Thomas Boulman, Simon Couturier, Eva Hoël, Philippe Karmin) was advised on this transaction by Advention (Alban Neveux, Eric Lesavre) on the strategic due diligence, EY Transaction Services (Jean-François Nadaud, Renaud Régner) on the financial due diligence and Mayer Brown for legal (Thomas Philippe, Clotilde Billat, Estelle Leclerc, Mélisande Sauze), tax (Elodie Deschamps, Olivia Sibieude) and financing (Patrick Teboul, Maud Bischoff, Julien Leris) matters.\r\n
          \r\n
          InnoVista Sensors was advised on this transaction by Canaccord Genuity (Nadim Barouki, Nicolas Royer), Latham &amp; Watkins (Alexander Benedetti, Julie Tchaglass, Alexandre Balat) on legal and corporate aspects, Linklaters (Oliver Sceales, Alex Szehidewicz) on legal and financing aspects\r\n
          \r\n
          Crouzet management was advised on this transaction by Delaby Dorison (Emmanuel Delaby, Florian Tumoine) for tax aspects and Bremond &amp; Associés (Christine Le Breton) for legal matters.\r\n
          \r\n
          - - -\r\n
          \r\n
          <strong>About LBO France</strong>\r\n
          \r\n
          As a key player in private equity with €3.6 bn of capital under management, LBO France is an independent company that has been supporting French companies in their growth for more than 30 years. Its strategy is based on 4 investment approaches in non-listed assets, managed by dedicated teams: (i) Mid Cap Buyout through the White Knight funds and Small Cap Buyout through the Hexagone/Small Caps Opportunities funds, (ii) Venture Capital through the SISA fund, (iii) Real Estate through the White Stone and Lapillus funds, (iv) Debt. LBO France is 100%-owned by its management and employs nearly 60 professionals.\r\n
          \r\n
          <a href="http://www.lbofrance.com">www.lbofrance.com</a>\r\n
          \r\n
          About Crouzet Since 1921, Crouzet has been committed to designing, manufacturing and supplying efficient components for automated systems to serve a wide range of applications in the Aerospace &amp; Defense market and in many Industrial equipment markets with a specific focus on applications such as Access control, Railway, Nuclear and Industrial valves markets.\r\n
          \r\n
          Crouzet’s product lines include Automation and Control devices, Motion products, Switches and Position Sensors, Cockpit Controls and (i) Electrical Protection solutions.\r\n
          \r\n
          Crouzet has a heritage of close collaboration with customers in the development of adapted products to fully customized solutions.\r\n
          \r\n
          Driven by innovation and customer satisfaction our teams are focused on delivering the right products and services for the right application, always meeting, often exceeding customers’ expectations.\r\n
          \r\n
          Crouzet is your trusted partner of choice to face industrial challenges of today and tomorrow.\r\n
          \r\n
          Crouzet is a company of InnoVista SensorsTM.\r\n
          \r\n
          <strong>Media Contacts</strong>\r\n
          \r\n
          For LBO France\r\n
          \r\n
          Citigate Dewe Rogerson\r\n
          \r\n
          Robert Amady - +33 1 53 32 78 91 - robert.amady@citigatedewerogerson.com\r\n
          \r\n
          Daiana Hirte - +33 1 53 32 78 90 - daiana.hirte@citigatedewerogerson.com\r\n
          \r\n
          For PAI Partners\r\n
          \r\n
          Greenbrook Communications:\r\n
          \r\n
          James Madsen / Annabel Clay (+44 20 7952 2000)\r\n
          \r\n
          DGM:\r\n
          \r\n
          Michel Calzaroni / Olivier Labesse / Hugues Schmitt (+33 1 40 70 11 89)\r\n
          \r\n
          For The Carlyle Group\r\n
          \r\n
          media.europe@carlyle.com\r\n
          \r\n
          and\r\n
          \r\n
          Steele &amp; Holt PR Agency\r\n
          \r\n
          Daphné Claude\r\n
          \r\n
          daphne@steeleandholt.com\r\n
          \r\n
          +33 6 66 58 81 92\r\n
          \r\n
          For Schneider Investor Relations (Schneider Electric):\r\n
          \r\n
          Amit Bhalla (+44 20 7592 8216)\r\n
          \r\n
          <strong>Press contact (Schneider Electric):</strong>\r\n
          \r\n
          Véronique Roquet-Montégon (+33 (0)1 41 29 70 76)\r\n
          \r\n
          <strong>Press Contact (DGM):</strong>\r\n
          \r\n
          Michel Calzaroni and Olivier Labesse (+33 (0)1 40 70 11 89)\r\n
          \r\n
          For Crouzet Françoise KAYZAKIAN | Communication Director\r\n
          \r\n
          Tel: 00 33 4 75 44 89 01\r\n
          \r\n
          E-mail : francoise.kayzakian@innovistasensors.com\r\n
          \r\n
          &nbsp;\r\n
          \r\n
          &nbsp;\r\n
          \r\n
          <a href="https://preprod.lbofrance.com/wp-content/uploads/2019/12/lbo-france-crouzet-eng-13122017.pdf">Read Press Release</a>
          """
        +post_date: "2017-12-13 09:04:04"
        +post_excerpt: ""
        +post_parent: 0
        +post_status: "publish"
        +post_title: "LBO France enters into a final agreement to acquire Crouzet"
        +post_type: "post"
        +slug: "lbo-france-enters-into-a-final-agreement-to-acquire-crouzet"
        #__type: null
        +"_wpml_media_featured": "1"
        +"_wpml_media_duplicate": "1"
        +"_yoast_wpseo_content_score": "30"
        +"_wp_old_date": "2019-12-18"
        +"banner": ""
        +"_banner": "field_5d0b8f67a8a14"
        +"linkedin": ""
        +"_linkedin": "field_5d0b8fa0a8a15"
        +"fichier": ""
        +"_fichier": "field_5d0b8faba8a16"
        +"_yoast_wpseo_primary_category": ""
        +"_edit_lock": "1581430034:1"
        +"_edit_last": "1"
        +"_wp_old_slug": "lbo-france-signe-un-accord-final-pour-lacquisition-de-crouzet"
        +"_last_translation_edit_mode": "native-editor"
        +"_wpml_media_has_media": "1"
        +"post_date_gmt": "2017-12-13 08:04:04"
        +"comment_status": "open"
        +"ping_status": "closed"
        +"post_password": ""
        +"post_name": "lbo-france-enters-into-a-final-agreement-to-acquire-crouzet"
        +"to_ping": ""
        +"pinged": ""
        +"post_modified": "2020-02-11 15:09:36"
        +"post_modified_gmt": "2020-02-11 14:09:36"
        +"post_content_filtered": ""
        +"guid": "http://preprod.lbofrance.com/lbo-france-signe-un-accord-final-pour-lacquisition-de-crouzet/"
        +"menu_order": 0
        +"post_mime_type": ""
        +"comment_count": "0"
        +"filter": "raw"
        +"status": "publish"
      }
      1 => Post {#428
        +ImageClass: "Timber\Image"
        +PostClass: "Timber\Post"
        +TermClass: "Timber\Term"
        +object_type: "post"
        +custom: array:16 [
          "_wpml_media_featured" => "1"
          "_wpml_media_duplicate" => "1"
          "_yoast_wpseo_content_score" => "30"
          "_wp_old_date" => "2019-12-18"
          "banner" => ""
          "_banner" => "field_5d0b8f67a8a14"
          "linkedin" => ""
          "_linkedin" => "field_5d0b8fa0a8a15"
          "fichier" => ""
          "_fichier" => "field_5d0b8faba8a16"
          "_yoast_wpseo_primary_category" => ""
          "_edit_lock" => "1581430046:1"
          "_edit_last" => "1"
          "_wp_old_slug" => "lbo-france-annonce-lacquisition-de-bexley"
          "_last_translation_edit_mode" => "native-editor"
          "_wpml_media_has_media" => "1"
        ]
        #___content: null
        #_permalink: null
        #_next: []
        #_prev: []
        #_css_class: null
        +id: 2143
        +ID: 2143
        +post_author: "1"
        +post_content: """
          <strong>Paris, Dec. 1 st 2017</strong> – LBO France today announced the acquisition of Bexley (“the Company”), a French specialty retailer of men’s high quality footwear at affordable price. The founding manager, Mr. Eric Botton, will keep a minority interest in the Company.\r\n
          \r\n
          Founded in 1985, Bexley rapidly established itself as one of the most successful French retailers of men’s footwear positioned in the affordable luxury segment and offering excellent quality-price ratio. Since then, the Company gradually diversified its product offering with men’s clothing (shirts, polos, pullovers, pants and suits) and accessories (belts, socks and small leather goods).\r\n
          \r\n
          In addition to its own store network, Bexley, which was a precursor in developing an omni-channel strategy, succeeded in setting up and launching an effective e-commerce platform as early as 1996, which today accounts for 1/3 of total sales with more than 400,000 customers.\r\n
          \r\n
          The Company employs 75 employees split between its head-office in Lyon and its 14 stores located in Paris, Lyon, Annecy, Aix, Marseille and Brussels.\r\n
          \r\n
          To accelerate growth and expansion in the coming years, Bexley has identified 3 main priorities:\r\n
          \r\n
          - Further develop its e-commerce platform focusing on the acquisition of new clients, its CRM tool, and an enhanced customer experience thanks to shopping via smartphones or tablets;\r\n
          \r\n
          - Continue geographical expansion in France with the opening of new stores in other French large cities or selected mid-sized cities;\r\n
          \r\n
          - Proactively identify prime location opportunities for new store openings in large European cities such as London or Berlin.\r\n
          \r\n
          Jérôme Guez, Partner LBO France, commented: <em>"We are very enthusiastic about this 5 th investment of our Mid Cap fund White Knight IX in Bexley. We look forward to work alongside the founding manager, Eric Botton, and his team in order to accompany Bexley in this new development chapter, by extending its store network, enhancing its e-commerce platform while maintaining very high profitability." </em>\r\n
          \r\n
          Eric Botton, Bexley’s founding manager, added: "I am very pleased to pursue Bexley’s growth story with LBO France, a financial sponsor in which, with the support of their Operating team, we have found a real understanding of our challenges and the clear willingness to invest alongside us in giving a whole new dimension to Bexley."\r\n
          \r\n
          Parties involved:\r\n
          \r\n
          LBO France\r\n
          \r\n
          - LBO France Team : Jérôme Guez, Guy Latourette, Laurent Mabileau, Karine Callec\r\n
          \r\n
          - Finance : 8 Advisory (Florence Khayat)\r\n
          \r\n
          - Legal : Mayer Brown (Xavier Jaspar ; Emily Pennec) Jones Day (Diane Sénéchal)\r\n
          \r\n
          - Strategy : Advention (Alban Neveu)\r\n
          \r\n
          - Tax : Arsene Taxand (Denis Andres)\r\n
          \r\n
          - - -\r\n
          \r\n
          <strong>About LBO France</strong>\r\n
          \r\n
          As a key player in private equity with €3.6bn of capital under management, LBO France is an independent company that has been supporting French companies in their growth for more than 30 years. Its strategy is based on 4 investment approaches in nonlisted assets, managed by dedicated teams: (i) Mid Cap Buyout through the White Knight funds and Small Cap Buyout through the Hexagone/Small Caps Opportunities funds, (ii) Venture Capital through the SISA fund, (iii) Real Estate through the White Stone and Lapillus funds, (iv) Debt. LBO France is 100%-owned by its management and employs nearly 60 professionals.\r\n
          \r\n
          <a href="http://www.lbofrance.com">www.lbofrance.com</a>\r\n
          \r\n
          <strong>Media Contacts</strong>\r\n
          \r\n
          For LBO France - Citigate Dewe Rogerson\r\n
          \r\n
          Robert Amady - +33 1 53 32 78 91 - robert.amady@citigatedewerogerson.com\r\n
          \r\n
          Daiana Hirte - +33 1 53 32 78 90 - daiana.hirte@citigatedewerogerson.com\r\n
          \r\n
          &nbsp;\r\n
          \r\n
          &nbsp;\r\n
          \r\n
          <a href="https://preprod.lbofrance.com/wp-content/uploads/2019/12/171201-lbo-france-pr-acq-bexley-final.pdf" target="_blank" rel="noopener noreferrer">Read Press Release</a>
          """
        +post_date: "2017-11-30 09:05:25"
        +post_excerpt: ""
        +post_parent: 0
        +post_status: "publish"
        +post_title: "LBO France announced the acquisition of Bexley"
        +post_type: "post"
        +slug: "lbo-france-announced-the-acquisition-of-bexley"
        #__type: null
        +"_wpml_media_featured": "1"
        +"_wpml_media_duplicate": "1"
        +"_yoast_wpseo_content_score": "30"
        +"_wp_old_date": "2019-12-18"
        +"banner": ""
        +"_banner": "field_5d0b8f67a8a14"
        +"linkedin": ""
        +"_linkedin": "field_5d0b8fa0a8a15"
        +"fichier": ""
        +"_fichier": "field_5d0b8faba8a16"
        +"_yoast_wpseo_primary_category": ""
        +"_edit_lock": "1581430046:1"
        +"_edit_last": "1"
        +"_wp_old_slug": "lbo-france-annonce-lacquisition-de-bexley"
        +"_last_translation_edit_mode": "native-editor"
        +"_wpml_media_has_media": "1"
        +"post_date_gmt": "2017-11-30 08:05:25"
        +"comment_status": "open"
        +"ping_status": "closed"
        +"post_password": ""
        +"post_name": "lbo-france-announced-the-acquisition-of-bexley"
        +"to_ping": ""
        +"pinged": ""
        +"post_modified": "2020-02-11 15:09:47"
        +"post_modified_gmt": "2020-02-11 14:09:47"
        +"post_content_filtered": ""
        +"guid": "http://preprod.lbofrance.com/lbo-france-annonce-lacquisition-de-bexley/"
        +"menu_order": 0
        +"post_mime_type": ""
        +"comment_count": "0"
        +"filter": "raw"
        +"status": "publish"
      }
      2 => Post {#429
        +ImageClass: "Timber\Image"
        +PostClass: "Timber\Post"
        +TermClass: "Timber\Term"
        +object_type: "post"
        +custom: array:14 [
          "_yoast_wpseo_content_score" => "60"
          "banner" => ""
          "_banner" => "field_5d0b8f67a8a14"
          "linkedin" => ""
          "_linkedin" => "field_5d0b8fa0a8a15"
          "fichier" => ""
          "_fichier" => "field_5d0b8faba8a16"
          "_yoast_wpseo_primary_category" => ""
          "_wpml_media_duplicate" => "1"
          "_wpml_media_featured" => "1"
          "_edit_lock" => "1581430076:1"
          "_edit_last" => "1"
          "_wp_old_slug" => "journee-digitale-lbo-france-17-novembre-2016"
          "_last_translation_edit_mode" => "native-editor"
        ]
        #___content: null
        #_permalink: null
        #_next: []
        #_prev: []
        #_css_class: null
        +id: 2144
        +ID: 2144
        +post_author: "1"
        +post_content: "<a href="https://preprod.lbofrance.com/wp-content/uploads/2019/12/journa-e-digitale-lbo-france-17-11-2016.pdf" target="_blank" rel="noopener noreferrer">Read Press Release</a>"
        +post_date: "2017-11-17 09:49:10"
        +post_excerpt: ""
        +post_parent: 0
        +post_status: "publish"
        +post_title: "Digital day LBO France - November 17, 2016"
        +post_type: "post"
        +slug: "digital-day-lbo-france-november-17-2016"
        #__type: null
        +"_yoast_wpseo_content_score": "60"
        +"banner": ""
        +"_banner": "field_5d0b8f67a8a14"
        +"linkedin": ""
        +"_linkedin": "field_5d0b8fa0a8a15"
        +"fichier": ""
        +"_fichier": "field_5d0b8faba8a16"
        +"_yoast_wpseo_primary_category": ""
        +"_wpml_media_duplicate": "1"
        +"_wpml_media_featured": "1"
        +"_edit_lock": "1581430076:1"
        +"_edit_last": "1"
        +"_wp_old_slug": "journee-digitale-lbo-france-17-novembre-2016"
        +"_last_translation_edit_mode": "native-editor"
        +"post_date_gmt": "2017-11-17 08:49:10"
        +"comment_status": "open"
        +"ping_status": "closed"
        +"post_password": ""
        +"post_name": "digital-day-lbo-france-november-17-2016"
        +"to_ping": ""
        +"pinged": ""
        +"post_modified": "2019-12-25 11:45:42"
        +"post_modified_gmt": "2019-12-25 10:45:42"
        +"post_content_filtered": ""
        +"guid": "http://preprod.lbofrance.com/journee-digitale-lbo-france-17-novembre-2016/"
        +"menu_order": 0
        +"post_mime_type": ""
        +"comment_count": "0"
        +"filter": "raw"
        +"status": "publish"
      }
      3 => Post {#430
        +ImageClass: "Timber\Image"
        +PostClass: "Timber\Post"
        +TermClass: "Timber\Term"
        +object_type: "post"
        +custom: array:14 [
          "_wpml_media_featured" => "1"
          "_wpml_media_duplicate" => "1"
          "_yoast_wpseo_content_score" => "30"
          "banner" => ""
          "_banner" => "field_5d0b8f67a8a14"
          "linkedin" => ""
          "_linkedin" => "field_5d0b8fa0a8a15"
          "fichier" => ""
          "_fichier" => "field_5d0b8faba8a16"
          "_yoast_wpseo_primary_category" => ""
          "_edit_lock" => "1581430092:1"
          "_edit_last" => "1"
          "_wp_old_slug" => "wandercraft-leve-15-me"
          "_last_translation_edit_mode" => "native-editor"
        ]
        #___content: null
        #_permalink: null
        #_next: []
        #_prev: []
        #_css_class: null
        +id: 2145
        +ID: 2145
        +post_author: "1"
        +post_content: """
          <strong>Wandercraft, world leader in autonomous exos</strong>\r\n
          \r\n
          Wandercraft leverages the most advanced robotics to let wheelchair users walk again.\r\n
          \r\n
          Founded in 2012, Wandercraft is the first company in the world to master the technologies required to design and control autonomous exos capable of human-like walk.\r\n
          \r\n
          Wandercraft has built a disruptive technological advantage in the algorithms of dynamic robotics that allow to mimic a human walker by creating a balanced gait from permanent unbalance, and in mechatronics and bio-mechanics.\r\n
          \r\n
          These breakthroughs have been achieved by one of the world’s best walk robotics team, gathering in Paris 30 experts in robotics, algorithms, clinical trials, quality, regulation and marketing. Wandercraft is actively hiring new talents in these fields.\r\n
          \r\n
          The company will communicate soon on the successful clinical trials of the exo’s version designed for rehabilitation centers. Other clinical trials are planned to prove that exos delivering a realistic walk should enable more effective treatments in rehabilitation centers, and provide mobility-impaired persons with autonomy in their daily living.\r\n
          \r\n
          Autonomous exos will change the lives of millions of wheelchair users and of their physicians, physios and carers.\r\n
          \r\n
          <strong> Top-notch investors to break the disability barrier</strong>\r\n
          \r\n
          After a 5-year stealth period, Wandercraft’s team announces the closing of a Series B round of €15 million with five top-tier investors : XAnge, IDinvest, Cemag Invest and Bpifrance, followed by the company’s historical shareholder LBO France.\r\n
          \r\n
          The funds raised will contribute to scaling Wandercraft’s team, obtaining the exo approval from healthcare authorities, entering the global rehabilitation center market and developing the exo’s personal version.\r\n
          \r\n
          <strong>Nicolas Simon, CEO and one of the three founders of Wandercraft</strong>, has declared: <em>« We are proud to have built a fantastic investor team around our mission, to bring autonomy to wheelchair users. They do not only bring funding but a unique combined experience in robotics, medical technologies and global growth. With the success of the first clinical trials and after 5 years of development on the leading edge of robotics and medicine, we now have all the resources needed to enter the market and contribute to breaking the disability barrier.” </em>\r\n
          \r\n
          <strong>Wandercraft</strong>\r\n
          \r\n
          Wandercraft’s job is to let walking-impaired persons walk again. Wandercraft develops and commercializes the first autonomous walk exo. With this exo, persons with Spinal Cord Injury stood up and walked, with a realistic gait , autonomously and without crutches in world premiere clinical trials.\r\n
          \r\n
          Wandercraft’s team works on the edge of walk robotics, with the best academic labs in dynamic robotics and reputable medical teams, in Europe and the USA. The company plans to soon distribute its exos to rehabilitation centers and is developing a personal version. It received many prestigious awards and is supported by ambitious investors.\r\n
          \r\n
          Wandercraft makes real the promise of robotics to offer an ordinary life to extraordinary people.\r\n
          \r\n
          <em> Jean-Louis Constanza, Chief Business Officer - jean-louis.constanza@wandercraft.eu - <a href="http://www.wandercraft.eu">www.wandercraft.eu </a></em>\r\n
          \r\n
          <strong>About LBO France</strong>\r\n
          \r\n
          As a key player in private equity with €3.6bn of capital under management, LBO France is an independent company which has been supporting French companies in their growth for more than 30 years. Its strategy is based on 4 investment approaches in non-listed companies, managed by dedicated teams: (i) Mid Cap buyout via the White Knight funds and Small Cap buyout via the Hexagone funds, (ii) Venture Capital via the Innovation Capital funds, (iii) Real Estate via the White Stone and Lapillus funds, (iv) Debt. www.lbofrance.com\r\n
          \r\n
          SISA fund, dedicated to digital healthcare and autonomy, includes 9 investments : Voluntis, FittingBox, Zesty, Wandercraft, Biomodex, H4D, Kayentis, OpenHealth Company and BioSerenity.\r\n
          \r\n
          <strong>Contact :</strong> Valery Huot, Partner – Head of Innovation Capital - valery.huot@lbofrance.com\r\n
          \r\n
          <strong>Contact Presse</strong>: Citigate Dewe Rogerson - Robert Amady - +33 6 72 63 08 91 - robert.amady@citigate.fr / Daiana Hirte - +33 7 60 90 89 12 - daiana.hirte@citigate.fr\r\n
          \r\n
          <strong>About XAnge </strong>\r\n
          \r\n
          XAnge is a Franco-German Venture Capital team with €400m under management, investing in Software, Internet, Hard tech and Impact entrepreneurs. XAnge is part of Siparex, a leading French private equity group.\r\n
          \r\n
          <a href="http://www.XAnge.fr">www.XAnge.fr </a>\r\n
          \r\n
          <strong>About Idinvest Partners </strong>\r\n
          \r\n
          With more than €8 billion under management, Idinvest Partners is a leading pan-European private equity firm focused on the mid-market segment. Idinvest Partners has developed several complementary areas of expertise including: investments in innovative European startups; mid-market direct lending (unitranche, senior loans and junior financing); primary and secondary investments in unlisted European companies, and private equity consulting. Founded under the name AGF Private Equity in 1997, Idinvest Partners was formerly part of Allianz until 2010 when it became an independent firm.\r\n
          \r\n
          <a href="http://www.idinvest.com">www.idinvest.com</a>\r\n
          \r\n
          <strong>About Cemag Invest </strong>\r\n
          \r\n
          Cemag Invest is a family office created following the divestiture of the pharmaceutical company HRA. It focuses on early dev and cap dev minority investment in healthcare companies and BtoB services, always alongside institutional investors.\r\n
          \r\n
          Catherine Dunand, President - c.dunand@cemag-invest.com\r\n
          \r\n
          <strong>About Bpifrance</strong>\r\n
          \r\n
          Equity investment are operated by Bpifrance Investissement. Bpifrance, a subsidiary of the French state and the Caisse des Dépôts and the entrepreneurs’ trusted partner, finances businesses from the seed phase to IPO, through loans, guarantees and equity investments. Bpifrance also provides operational services and strong support for innovation, export, and external growth in parnertship with Business France. Bpifrance offers to businesses a large range of financing opportunities at each key step of their development, including offers adapted to regional specificities. With its 50 regional offices (90% of decisions are made locally) Bpifrance represents a strategic tool for economic competitiveness dedicated to entrepreneurs. Bpifrance acts as a back-up for initiatives driven by the French State and the Regions to tackle 3 goals:\r\n
          \r\n
          · Contributing to SME’s growth\r\n
          \r\n
          · Preparing tomorrow’s competitiveness\r\n
          \r\n
          · Contributing to the development of a positive entrepreneur ecosystem.\r\n
          \r\n
          With Bpifrance, businesses benefit from a powerful, efficient and close representative, to answer all their needs in terms of financing, innovation and investment.\r\n
          \r\n
          www.bpifrance.fr Twitter: @bpifrance / @bpifrancepresse\r\n
          \r\n
          Nicolas Jehly – nicolas.jehly@bpifrance.fr - 01 41 79 95 12\r\n
          \r\n
          &nbsp;\r\n
          \r\n
          &nbsp;\r\n
          \r\n
          <a href="https://preprod.lbofrance.com/wp-content/uploads/2019/12/wandercraft-pr-series-b-280917.pdf" target="_blank" rel="noopener noreferrer">Read Press Release</a>
          """
        +post_date: "2017-09-28 09:06:27"
        +post_excerpt: ""
        +post_parent: 0
        +post_status: "publish"
        +post_title: "Wandercraft raises 15m"
        +post_type: "post"
        +slug: "wandercraft-raises-15m"
        #__type: null
        +"_wpml_media_featured": "1"
        +"_wpml_media_duplicate": "1"
        +"_yoast_wpseo_content_score": "30"
        +"banner": ""
        +"_banner": "field_5d0b8f67a8a14"
        +"linkedin": ""
        +"_linkedin": "field_5d0b8fa0a8a15"
        +"fichier": ""
        +"_fichier": "field_5d0b8faba8a16"
        +"_yoast_wpseo_primary_category": ""
        +"_edit_lock": "1581430092:1"
        +"_edit_last": "1"
        +"_wp_old_slug": "wandercraft-leve-15-me"
        +"_last_translation_edit_mode": "native-editor"
        +"post_date_gmt": "2017-09-28 07:06:27"
        +"comment_status": "open"
        +"ping_status": "closed"
        +"post_password": ""
        +"post_name": "wandercraft-raises-15m"
        +"to_ping": ""
        +"pinged": ""
        +"post_modified": "2020-02-11 15:10:32"
        +"post_modified_gmt": "2020-02-11 14:10:32"
        +"post_content_filtered": ""
        +"guid": "http://preprod.lbofrance.com/wandercraft-leve-15-me/"
        +"menu_order": 0
        +"post_mime_type": ""
        +"comment_count": "0"
        +"filter": "raw"
        +"status": "publish"
      }
      4 => Post {#434
        +ImageClass: "Timber\Image"
        +PostClass: "Timber\Post"
        +TermClass: "Timber\Term"
        +object_type: "post"
        +custom: array:16 [
          "_wpml_media_featured" => "1"
          "_wpml_media_duplicate" => "1"
          "_yoast_wpseo_content_score" => "30"
          "_wp_old_date" => "2019-12-18"
          "banner" => ""
          "_banner" => "field_5d0b8f67a8a14"
          "linkedin" => ""
          "_linkedin" => "field_5d0b8fa0a8a15"
          "fichier" => ""
          "_fichier" => "field_5d0b8faba8a16"
          "_yoast_wpseo_primary_category" => ""
          "_edit_lock" => "1581430109:1"
          "_edit_last" => "1"
          "_wp_old_slug" => "bioserenity-champion-francais-de-la-e-sante-leve-15-me"
          "_last_translation_edit_mode" => "native-editor"
          "_wpml_media_has_media" => "1"
        ]
        #___content: null
        #_permalink: null
        #_next: []
        #_prev: []
        #_css_class: null
        +id: 2146
        +ID: 2146
        +post_author: "1"
        +post_content: """
          <strong>Paris, September 20th 2017 - Start-up specialized in connected solutions for patients, BioSerenity closed a Series A round of €15 million led by LBO France and investments from Idinvest Partners and PSIM fund managed by Bpifrance. </strong>\r\n
          \r\n
          BioSerenity has developed several product lines to facilitate the diagnosis and monitoring of patients. The high growth medtech company collaborated with several large scale university hospitals across the globe and plans on leveraging the new round of financing to continue its industrialization, and internationalization. With over 80 employees, BioSerenity has recently opened new offices in France, China and the United-States.\r\n
          \r\n
          BioSerenity offers disease specific full-stack solutions to speed up diagnosis, facilitate the follow-up and help calibrate treatments. The company currently focuses on 4 main pathological areas : Epilepsy, Cardiovascular diseases, Pregnancy monitoring and Sleep disorders.\r\n
          \r\n
          BioSerenity has successfully deployed a collaborative business model with the pharmaceutical industry through partnerships that rely on the creation of a complete technological solution (hardware device, smartphone app, medical cloud, and an automatic analysis of data by Artificial Intelligence). Each partnership is centered around a disease area in which the pharmaceutical company is specialized.\r\n
          \r\n
          The pharmaceutical companies use their global reach to deploy the solution around the world and take advantage of the devices for their own clinical trials or companion diagnostics strategy\r\n
          \r\n
          <img class="alignnone size-medium wp-image-3279" src="https://preprod.lbofrance.com/wp-content/uploads/2017/09/Capture-300x129.png" alt="" width="300" height="129" />\r\n
          \r\n
          <strong>Pierre Frouin, CEO and Founder of BioSerenity</strong> believes that the success of BioSerenity can be attributed to a combination of factors:<em> “A number of startups focus on a single technology block whereas BioSerenity has a solution based approach ranging from the capture of data to the analysis in a medical context, this makes us one of the only companies in our domain able to generate the expected medical gains. We have developed an important IP portfolio and we have a top-tier team that collaborates with a large ecosystem. BioSerenity was born in a hospital environment in the Brain and Spine Institute (icminstitute.org) and our pharmaceutical partners appreciate our deep understanding of clinical challenges”. For Pierre Frouin, “with this fund raising, we obtain not only the means to finance our growth but also investors who have expertise in the digital and medical innovation, two sectors that intersect at BioSerenity</em>”\r\n
          \r\n
          <strong> Valéry Huot, Partner and Head of Innovation Capital of LBO France</strong>, declares: <em>“We are glad to bring our support to BioSerenity and its management team. This is the 9th investment of our SISA fund dedicated to innovating companies focused on digital health in Europe. BioSerenity has an impressive track record and we are convinced that the company will continue its high growth. BioSerenity has all the assets to become a major player in bringing solutions for connected patients around the world.”</em>\r\n
          \r\n
          <strong> Emmanuel Audouard, Director of the PSIM fund at Bpifrance</strong>, adds : <em>“BioSerenity is one of the most promising MedTech companies in its domain. The company brings an innovative solution to diagnostics and monitoring problems. We are glad to support its growth by mobilizing our PSIM fund reserved for winners of the World Wide Innovation Challenge side by side with Idinvest Partners and LBO France.” </em>\r\n
          \r\n
          <strong>Luc Maruenda, Partner at Idinvest Partners</strong> concludes : <em>"BioSerenity has been executing brilliantly these last two years with the help of a team of 80 dynamic talents and academic, industrial and clinical partners of high quality. We are delighted to renew our trust in the management team of BioSerenity by reinvesting and welcoming new co-investors " </em>\r\n
          \r\n
          <strong>About Bioserenity </strong>\r\n
          \r\n
          BioSerenity, is a company created in 2014 and located inside the ICM Brain and Spine Institute (icm-institute.org) in La Pitié-Salpêtrière hospital, one of the largest and oldest hospitals in Europe. BioSerenity has a shared research lab with the ICM. With over 80 employees, BioSerenity quickly became one of the technology leaders in smart medical solutions for remote monitoring thanks to an integrated network of partners in the hospital, research and pharmaceutical industry.\r\n
          \r\n
          <a href="http://www.bioserenity.com">www.bioserenity.com</a>\r\n
          \r\n
          Contact : corporate@bioserenity.com - Téléphone : +33 1 84 25 64 27\r\n
          \r\n
          <strong> About Idinvest Partners</strong>\r\n
          \r\n
          The mission of Idinvest Partners, a European leader in financing small and medium-sized enterprises, is to fund European businesses at various stages of growth. With more than €8 billion under management, we can harness a range of complementary expertise to help businesses grow quickly using equity and private debt investment, both directly and via private equity funds. Since its formation in 1997, Idinvest has financed more than 3,500 European businesses through its three business lines: Venture &amp; Growth Capital, Private Debt and Private Funds Group.\r\n
          \r\n
          <a href="http://www.idinvest.com">www.idinvest.com </a>\r\n
          \r\n
          Contact : Luc Maruenda, Partner, lm@idinvest.com\r\n
          \r\n
          <strong>About LBO France</strong>\r\n
          \r\n
          As a key player in private equity with €3.6bn of capital under management, LBO France is an independent company which has been supporting French companies in their growth for more than 30 years. Its strategy is based on 4 investment approaches in non-listed companies, managed by dedicated teams: (i) Mid Cap buyout via the White Knight funds and Small Cap buyout via the Hexagone funds, (ii) Venture Capital via the Innovation Capital funds, (iii) Real Estate via the White Stone and Lapillus funds, (iv) Debt.\r\n
          \r\n
          <a href="http://www.lbofrance.com">www.lbofrance.com</a>\r\n
          \r\n
          BioSerenity is the 9th portfolio company of SISA fund, dedicated to digital healthcare and autonomy, following the investments in Voluntis, FittingBox, Zesty, Wandercraft, Biomodex, H4D, Kayentis and OpenHealth.\r\n
          \r\n
          Contact : Valery Huot, Partner – Head of Innovation Capital - valery.huot@lbofrance.com\r\n
          \r\n
          Press Contact : Citigate Dewe Rogerson - Robert Amady - - +33 6 72 63 08 91 - robert.amady@citigate.fr / Daiana Hirte - +33 7 60 90 89 12 - daiana.hirte@citigate.fr\r\n
          \r\n
          <strong>About Bpifrance</strong>\r\n
          \r\n
          Bpifrance, a subsidiary of Caisse des Dépôts and the French State, is a trusted partner of entrepreneurs which provides companies with credit, collateral and equity financing support - from start up through to stock exchange listing. In partnership with Business France, Bpifrance also provides guidance and enhanced support services for innovation, external growth, and exports. Bpifrance offers each company a range of financing for each key stage in its development, and an offer adapted to regional particularities. With 48 regional offices (90% of decisions are made regionally), Bpifrance offers entrepreneurs a tool for economic competitiveness. Bpifrance works in support of the public policies pursued nationally and regionally by the French government, to meet three objectives:\r\n
          \r\n
          • support the growth of businesses\r\n
          \r\n
          • prepare for future competitiveness\r\n
          \r\n
          • contribute to the development of an ecosystem that encourages entrepreneurship.\r\n
          \r\n
          With Bpifrance, companies benefit from a strong and effective local contact able to meet all their financial, innovation and investment needs.\r\n
          \r\n
          <a href="http://www.bpifrance.fr"> www.bpifrance.fr</a>\r\n
          \r\n
          Contact : Nicolas Jehly – nicolas.jehly@bpifrance.fr - +33 1 41 79 95 12\r\n
          \r\n
          &nbsp;\r\n
          \r\n
          &nbsp;\r\n
          \r\n
          <a href="https://preprod.lbofrance.com/wp-content/uploads/2019/12/en-pr-bioserenity-raises-eur15m-20092017.pdf" target="_blank" rel="noopener noreferrer">Read Press Release</a>
          """
        +post_date: "2017-09-20 09:08:28"
        +post_excerpt: ""
        +post_parent: 0
        +post_status: "publish"
        +post_title: "BioSerenity, digital health champion, raises 15m"
        +post_type: "post"
        +slug: "bioserenity-digital-health-champion-raises-15m"
        #__type: null
        +"_wpml_media_featured": "1"
        +"_wpml_media_duplicate": "1"
        +"_yoast_wpseo_content_score": "30"
        +"_wp_old_date": "2019-12-18"
        +"banner": ""
        +"_banner": "field_5d0b8f67a8a14"
        +"linkedin": ""
        +"_linkedin": "field_5d0b8fa0a8a15"
        +"fichier": ""
        +"_fichier": "field_5d0b8faba8a16"
        +"_yoast_wpseo_primary_category": ""
        +"_edit_lock": "1581430109:1"
        +"_edit_last": "1"
        +"_wp_old_slug": "bioserenity-champion-francais-de-la-e-sante-leve-15-me"
        +"_last_translation_edit_mode": "native-editor"
        +"_wpml_media_has_media": "1"
        +"post_date_gmt": "2017-09-20 07:08:28"
        +"comment_status": "open"
        +"ping_status": "closed"
        +"post_password": ""
        +"post_name": "bioserenity-digital-health-champion-raises-15m"
        +"to_ping": ""
        +"pinged": ""
        +"post_modified": "2020-02-11 15:10:43"
        +"post_modified_gmt": "2020-02-11 14:10:43"
        +"post_content_filtered": ""
        +"guid": "http://preprod.lbofrance.com/bioserenity-champion-francais-de-la-e-sante-leve-15-me/"
        +"menu_order": 0
        +"post_mime_type": ""
        +"comment_count": "0"
        +"filter": "raw"
        +"status": "publish"
      }
      5 => Post {#442
        +ImageClass: "Timber\Image"
        +PostClass: "Timber\Post"
        +TermClass: "Timber\Term"
        +object_type: "post"
        +custom: array:16 [
          "_yoast_wpseo_content_score" => "30"
          "_wp_old_date" => "2019-12-18"
          "banner" => ""
          "_banner" => "field_5d0b8f67a8a14"
          "linkedin" => ""
          "_linkedin" => "field_5d0b8fa0a8a15"
          "fichier" => ""
          "_fichier" => "field_5d0b8faba8a16"
          "_yoast_wpseo_primary_category" => "70"
          "_wpml_media_duplicate" => "1"
          "_wpml_media_featured" => "1"
          "_edit_lock" => "1581430113:1"
          "_edit_last" => "1"
          "_wp_old_slug" => "openhealth-company-le-8eme-investissement-du-fonds-sisa-gere-par-lbo-france-innovation-capital"
          "_last_translation_edit_mode" => "native-editor"
          "_wpml_media_has_media" => "1"
        ]
        #___content: null
        #_permalink: null
        #_next: []
        #_prev: []
        #_css_class: null
        +id: 2147
        +ID: 2147
        +post_author: "1"
        +post_content: """
          <strong>Paris, 13th September 2017 – OpenHealth Company, specialised in real-time healthcare data collection and analysis, closed a financing round over €5m led by LBO France / Innovation Capital. In September, it will launch The Hub, the largest healthcare data analysis platform available in France.</strong>\r\n
          \r\n
          OpenHealth’s Hub aggregates data from multiple sources to offer a variety of powerful capabilities for analysis in three major areas:\r\n
          \r\n
          - Sales and marketing: Consumer data on all types of healthcare products (more than 200,000 referenced) aimed at the pharmaceutical industry and marketing research firms. These data are available in real time and include sales in pharmacies and supermarkets thanks to a partnership with IRI.\r\n
          \r\n
          - Health watch: Analysis and mapping by geographical area to conduct epidemiological analyses, monitor healthcare product sales and track health events in real time.\r\n
          \r\n
          - Safe use of healthcare products: The analysis of proper medication use and the creation of online cohorts provide information about how medicines and healthcare products are used in real-life (age of patients treated, related treatments, compliance with contraindications and good practices, treatment regimens, etc.), which is essential for risk management by manufacturers and health authorities.\r\n
          \r\n
          These new services will make it possible for data to be explored and analysed through a simple web browser, thereby giving all stakeholders, healthcare industries, public authorities, consulting firms and research organisations easy access to relevant data.\r\n
          \r\n
          The analysis of healthcare data will gradually change how we understand various challenges in the healthcare sector. After massive investments in many developed countries, and especially North America, this was the first fundraising operation to be held in France in this field. Through its SISA fund dedicated to companies in the European digital healthcare sector, LBO France / Innovation Capital led the round over €5m. In 2017, OpenHealth Company also received financial support from Bpifrance.\r\n
          \r\n
          <em> “By making data more accessible to stakeholders and allowing them to develop indicators that were previously complex and costly to obtain, we are accelerating the production of new knowledge”, says Dr Patrick Guérin, President of OpenHealth. “Either for market studies, post-authorisation studies on health product use or healthcare safety, OpenHealth’s Hub is helping to make deep changes to how we understand these data while maintaining the strictest level of privacy”</em>, explains <strong>CEO Dr Jean-Yves Robin.</strong>\r\n
          \r\n
          Ingrid Rayez, Director of Investment at LBO France / Innovation Capital, adds, “We are thrilled to work with OpenHealth and its experienced leaders. This is the eighth investment of our SISA fund dedicated to digital healthcare and autonomy in Europe. The collection and real-time analysis of healthcare data has become key, especially for monitoring the use of healthcare products in real world. With The Hub, OpenHealth is well positioned to become leader in this sector.”\r\n
          \r\n
          Contacts: For OpenHealth:\r\n
          \r\n
          Contact:\r\n
          \r\n
          Catherine Commaille-Chapus - +33 2 97 68 37 00 - c.commaille-chapus@openhealth.fr\r\n
          \r\n
          Press contact: LauMa communication\r\n
          \r\n
          Laurie Marcellesi - +33 1 73 03 05 20 - laurie.marcellesi@lauma-communication.com\r\n
          \r\n
          For LBO France / Innovation Capital:\r\n
          \r\n
          Contact:\r\n
          \r\n
          Ingrid Rayez - +33 1 80 06 99 15 - ingrid.rayez@lbofrance.com\r\n
          \r\n
          Press contact: Citigate Dewe Rogerson\r\n
          \r\n
          Robert Amady - +33 1 53 32 78 91 - +33 6 72 63 08 91 - robert.amady@citigate.fr\r\n
          \r\n
          Daiana Hirte - +33 1 53 32 78 90 - +33 7 60 90 89 12 - daiana.hirte@citigate.fr\r\n
          \r\n
          <strong> About OpenHealth</strong>\r\n
          \r\n
          OpenHealth Company, founded in 2015 by Patrick Guérin, former President of Celtipharm, and JeanYves Robin, former Director of ASIP Santé, is the leading French company in the collection and realtime analysis of healthcare data. This expertise is supported by the processing of multiple data sources, including pharmacy sales data (a panel of more than 10,000 pharmacies, retained by the French High Authority of Health – HAS and the National Agency for the Safety of Medicine and Health Products – ANSM), geographical data, longitudinal patient data, outpatient medical data and international data. The company provides industrial and institutional customers with new flexible solutions and unique sector-specific support with its multidisciplinary team of doctors, pharmacists, statisticians, market access experts and industry executives. OpenHealth, which has around 50 employees at its Parisian headquarters and production site in Vannes, France, has projected its 2017 turnover at around €10m. The company is an accredited personal healthcare data host.\r\n
          \r\n
          For more information, go to <a href="http://www.openhealth.fr.">www.openhealth.fr. </a>\r\n
          \r\n
          <strong>About LBO France / Innovation Capital</strong>\r\n
          \r\n
          As a key player in private equity with €3.6bn of capital under management, LBO France is an independent company which has been supporting French companies in their growth for more than 30 years. Its strategy is based on four investment approaches in non-listed companies, managed by dedicated teams: (i) Mid Cap buyout via the White Knight funds and Small Cap buyout via the Hexagone funds, (ii) Venture Capital via the Innovation Capital funds, (iii) Real Estate via the White Stone and Lapillus funds, (iv) Debt. The SISA fund, Innovation Capital’s latest fund dedicated to digital healthcare and autonomy, is today strong of 8 portfolio companies : Voluntis, FittingBox, Zesty, Wandercraft, Biomodex, H4D, Kayentis and OpenHealth.\r\n
          \r\n
          &nbsp;\r\n
          \r\n
          &nbsp;\r\n
          \r\n
          <a href="https://preprod.lbofrance.com/wp-content/uploads/2019/12/lbo-france-innovation-capital-pr-openhealth-company-13092017.pdf" target="_blank" rel="noopener noreferrer">Read Press Release</a>
          """
        +post_date: "2017-09-13 09:13:24"
        +post_excerpt: ""
        +post_parent: 0
        +post_status: "publish"
        +post_title: "OpenHealth Company, the 8th investment of SISA fund managed by LBO France / Innovation Capital"
        +post_type: "post"
        +slug: "openhealth-company-the-8th-investment-of-sisa-fund-managed-by-lbo-france-innovation-capital"
        #__type: null
        +"_yoast_wpseo_content_score": "30"
        +"_wp_old_date": "2019-12-18"
        +"banner": ""
        +"_banner": "field_5d0b8f67a8a14"
        +"linkedin": ""
        +"_linkedin": "field_5d0b8fa0a8a15"
        +"fichier": ""
        +"_fichier": "field_5d0b8faba8a16"
        +"_yoast_wpseo_primary_category": "70"
        +"_wpml_media_duplicate": "1"
        +"_wpml_media_featured": "1"
        +"_edit_lock": "1581430113:1"
        +"_edit_last": "1"
        +"_wp_old_slug": "openhealth-company-le-8eme-investissement-du-fonds-sisa-gere-par-lbo-france-innovation-capital"
        +"_last_translation_edit_mode": "native-editor"
        +"_wpml_media_has_media": "1"
        +"post_date_gmt": "2017-09-13 07:13:24"
        +"comment_status": "open"
        +"ping_status": "closed"
        +"post_password": ""
        +"post_name": "openhealth-company-the-8th-investment-of-sisa-fund-managed-by-lbo-france-innovation-capital"
        +"to_ping": ""
        +"pinged": ""
        +"post_modified": "2020-02-11 15:10:52"
        +"post_modified_gmt": "2020-02-11 14:10:52"
        +"post_content_filtered": ""
        +"guid": "http://preprod.lbofrance.com/openhealth-company-le-8eme-investissement-du-fonds-sisa-gere-par-lbo-france-innovation-capital/"
        +"menu_order": 0
        +"post_mime_type": ""
        +"comment_count": "0"
        +"filter": "raw"
        +"status": "publish"
      }
      6 => Post {#443
        +ImageClass: "Timber\Image"
        +PostClass: "Timber\Post"
        +TermClass: "Timber\Term"
        +object_type: "post"
        +custom: array:16 [
          "_wpml_media_featured" => "1"
          "_wpml_media_duplicate" => "1"
          "_yoast_wpseo_content_score" => "30"
          "_wp_old_date" => "2019-12-18"
          "banner" => ""
          "_banner" => "field_5d0b8f67a8a14"
          "linkedin" => ""
          "_linkedin" => "field_5d0b8fa0a8a15"
          "fichier" => ""
          "_fichier" => "field_5d0b8faba8a16"
          "_yoast_wpseo_primary_category" => ""
          "_edit_lock" => "1581430282:1"
          "_edit_last" => "1"
          "_wp_old_slug" => "lbo-france-annonce-lacquisition-de-la-societe-piex"
          "_last_translation_edit_mode" => "native-editor"
          "_wpml_media_has_media" => "1"
        ]
        #___content: null
        #_permalink: null
        #_next: []
        #_prev: []
        #_css_class: null
        +id: 2149
        +ID: 2149
        +post_author: "1"
        +post_content: """
          <strong>Paris, September 4, 2017</strong> – LBO France announced the acquisition of a majority stake in PIEX (“the Company”). This buy-out operation is led partnering with Mr. Bertrand Talbotier and the Company’s management team, as well as funds AfricInvest Europe, BNP Paribas Développement, BPI and Trocadéro Capital Partners.\r\n
          \r\n
          PIEX is a specialized distribution company which was founded in 1979 by Mr. Robert Jamain, incumbent CEO, and which, over the past years, grew to become a key player in the distribution of pharmaceutical and parapharmaceutical products in French-speaking Sub-Saharan Africa.\r\n
          \r\n
          Its unique positioning, based upon its strong expertise of targeted markets and ability to handle products from many pharmaceutical and parapharmaceutical companies in a professional, agile and flexible way, positions PIEX as an indispensable and trusted partner of groups to enter the African market through a wide network of local wholesalers.\r\n
          \r\n
          Thanks to its proven know-how and tailor-made logistics, the Company has, over the past 40 years, secured privileged relationships with its historical clients, worldwide’s pharmaceutical groups and health professionals which mainly operate in Sub-Saharan Africa, and in Central Asia from now on.\r\n
          \r\n
          PIEX has recorded an average annual growth (CAGR) in its revenue of ca. 12% since 2005 and has reached €80 million in revenue in 2016, spread over more than 30 countries, including Ivory Coast (22%), Senegal (14%) and Cameroon (10%).\r\n
          \r\n
          The Company distributes more than 750 products to ca. 350 clients.\r\n
          \r\n
          In order to increase PIEX’s revenue and market shares, LBO France has teamed up with a new management team, led by Bertrand Talbotier (seasoned entrepreneur with more than 20-year experience in the pharmaceutical industry and a strong knowledge of the African market), and identified 3 main priorities:\r\n
          \r\n
          - Further develop its client base to include new pharmaceutical groups and biotech companies;\r\n
          \r\n
          - Expand its business activities into new high-growth geographical markets;\r\n
          \r\n
          - Broaden its offer of high value-added services.\r\n
          \r\n
          <strong>Jean-Marie Leroy, Partner at LBO France</strong>, commented: <em>"This primary LBO perfectly illustrates our strategy of accompanying family-owned companies in their new development phase and led by a new management team. This acquisition is a meaningful choice made by LBO France in its investment options and the very nature of PIEX, a company operating in the heath sector and mainly towards the African market, demonstrates our commitment to the ESG principles guiding our investment approach." </em>\r\n
          \r\n
          <strong>Bertrand Talbotier, PIEX’s newly appointed CEO</strong>, added:<em> "PIEX’s acquisition by LBO France and its management team is a key milestone in the implementation of our defined strategy which aims at creating a leading player in the distribution of pharmaceutical products. Our conviction for PIEX is to improve patients’ life and health in targeted geographical areas and bring high quality genuine products and services within reach to historically disadvantaged people and countries. Our ambition is to build a model which is known for being innovative, profitable, long-lasting, respectful and exemplary in its operational roll-out. I am very honored to be given the opportunity to lead this ambitious project, alongside LBO France and our partners, towards achieving the expected success." </em>\r\n
          \r\n
          Parties involved:\r\n
          \r\n
          LBO France\r\n
          \r\n
          - LBO France Team: Jean-Marie Leroy, Partner Small Cap\r\n
          \r\n
          LBO France Emmanuel Fiorentino, Investment Manager\r\n
          \r\n
          Karine Callec, General Counsel\r\n
          \r\n
          - Finance: Grant Thornton : Emmanuel Riou\r\n
          \r\n
          Anissa Ghaouti\r\n
          \r\n
          - Legal: Jeantet : Philippe Matignon\r\n
          \r\n
          Pascal Georges\r\n
          \r\n
          Nicolas Goetz\r\n
          \r\n
          Gabriel di Chiara\r\n
          \r\n
          Camille Perodeau\r\n
          \r\n
          - Strategy : Alcimed : Vincent Genet\r\n
          \r\n
          Loïc Marce\r\n
          \r\n
          - HR : Cabinet Bilanciel\r\n
          \r\n
          Sophie Touttée Henrotte\r\n
          \r\n
          - - -\r\n
          \r\n
          <strong>About LBO France </strong>\r\n
          \r\n
          As a key player in private equity with €3.6bn of capital under management, LBO France is an independent company that has been supporting French companies in their growth for more than 30 years. Its strategy is based on 4 investment approaches in non-listed assets, managed by dedicated teams: (i) Mid Cap buyout through the White Knight funds and Small Cap buyout through the Hexagone funds, (ii) Innovation-Capital through the Innovation Capital funds, (iii) Real Estate through the White Stone and Lapillus funds, (iv) Debt. LBO France is 100%-owned by its management and employs almost 60 professionals.\r\n
          \r\n
          <a href="http://www.lbofrance.com">www.lbofrance.com </a>\r\n
          \r\n
          <strong>Media Contacts For LBO France</strong> - Citigate Dewe Rogerson\r\n
          \r\n
          Robert Amady - +33 1 53 32 78 91 - +33 6 72 63 08 91 - robert.amady@citigate.fr\r\n
          \r\n
          Daiana Hirte - +33 1 53 32 78 90 - +33 7 60 90 89 12 - daiana.hirte@citigate.fr\r\n
          \r\n
          &nbsp;\r\n
          \r\n
          &nbsp;\r\n
          \r\n
          <a href="https://preprod.lbofrance.com/wp-content/uploads/2019/12/170904-lbo-france-acq-piex-press-release-final.pdf" target="_blank" rel="noopener noreferrer">Read Press Release</a>
          """
        +post_date: "2017-09-04 09:16:44"
        +post_excerpt: ""
        +post_parent: 0
        +post_status: "publish"
        +post_title: "LBO France announced the acquisition of PIEX"
        +post_type: "post"
        +slug: "lbo-france-announced-the-acquisition-of-piex-2"
        #__type: null
        +"_wpml_media_featured": "1"
        +"_wpml_media_duplicate": "1"
        +"_yoast_wpseo_content_score": "30"
        +"_wp_old_date": "2019-12-18"
        +"banner": ""
        +"_banner": "field_5d0b8f67a8a14"
        +"linkedin": ""
        +"_linkedin": "field_5d0b8fa0a8a15"
        +"fichier": ""
        +"_fichier": "field_5d0b8faba8a16"
        +"_yoast_wpseo_primary_category": ""
        +"_edit_lock": "1581430282:1"
        +"_edit_last": "1"
        +"_wp_old_slug": "lbo-france-annonce-lacquisition-de-la-societe-piex"
        +"_last_translation_edit_mode": "native-editor"
        +"_wpml_media_has_media": "1"
        +"post_date_gmt": "2017-09-04 07:16:44"
        +"comment_status": "open"
        +"ping_status": "closed"
        +"post_password": ""
        +"post_name": "lbo-france-announced-the-acquisition-of-piex-2"
        +"to_ping": ""
        +"pinged": ""
        +"post_modified": "2020-02-11 15:11:21"
        +"post_modified_gmt": "2020-02-11 14:11:21"
        +"post_content_filtered": ""
        +"guid": "http://preprod.lbofrance.com/lbo-france-annonce-lacquisition-de-la-societe-piex/"
        +"menu_order": 0
        +"post_mime_type": ""
        +"comment_count": "0"
        +"filter": "raw"
        +"status": "publish"
      }
      7 => Post {#444
        +ImageClass: "Timber\Image"
        +PostClass: "Timber\Post"
        +TermClass: "Timber\Term"
        +object_type: "post"
        +custom: array:15 [
          "_wpml_media_featured" => "1"
          "_wpml_media_duplicate" => "1"
          "_yoast_wpseo_content_score" => "60"
          "_wp_old_date" => "2019-12-18"
          "banner" => ""
          "_banner" => "field_5d0b8f67a8a14"
          "linkedin" => ""
          "_linkedin" => "field_5d0b8fa0a8a15"
          "fichier" => ""
          "_fichier" => "field_5d0b8faba8a16"
          "_yoast_wpseo_primary_category" => ""
          "_edit_lock" => "1581430145:1"
          "_edit_last" => "1"
          "_wp_old_slug" => "lbo-france-annonce-lacquisition-de-la-societe-serapid"
          "_last_translation_edit_mode" => "native-editor"
        ]
        #___content: null
        #_permalink: null
        #_next: []
        #_prev: []
        #_css_class: null
        +id: 2150
        +ID: 2150
        +post_author: "1"
        +post_content: """
          <strong>Paris, 27 July 2017</strong> – LBO France announced the acquisition of a majority stake in SERAPID (“the company”). This buy-out operation is led partnering with two managers, Emeric Labesse and Guillaume Davies, as well as the historic shareholder Saïd Lounis.\r\n
          \r\n
          SERAPID is a French company created in 1972. As the creator of the rigid chain technology, SERAPID designs and manufactures telescopic mechanical links used for the horizontal and vertical displacement of heavy loads and the rapid change of press tools. Thanks to its intrinsic advantages (clean, reliable and compact technology), the rigid chain is a real alternative to traditional mechanical and hydraulic solutions that meet the needs of various industries (automotive, nuclear, aerospace, medical and entertainment).\r\n
          \r\n
          Building on its success, the company reached €26m of sales in 2016, of which 70% in industrial equipment and 30% in scenic and architectural.\r\n
          \r\n
          Headquartered in Dieppe, the company already has a very strong international presence, with 59% of its revenues generated in Europe, 37% in North America and 4% in Asia. The company employs 116 employees.\r\n
          \r\n
          In order to accelerate its development in the coming years, SERAPID has identified three major axes:\r\n
          \r\n
          - Accelerating the international deployment of historical applications;\r\n
          \r\n
          - Deployment of new applications in the medical, defense and lift markets for freight, trucks and cars;\r\n
          \r\n
          - Strengthening the existing organization.\r\n
          \r\n
          <strong>Jean-Marie Leroy, Partner at LBO France</strong>, commented: <em>« This primary LBO, negotiated off-market in the frame of a proprietary transaction, illustrates our small cap strategy perfectly. We support French companies willing to expand abroad. » </em>\r\n
          \r\n
          Parties involved:\r\n
          \r\n
          LBO France\r\n
          \r\n
          - LBO France team : Jean-Marie Leroy, Partner Small Cap LBO France\r\n
          \r\n
          Louis de Lummen, Investment Manager\r\n
          \r\n
          Karine Callec, General Counsel\r\n
          \r\n
          - Finance : EY : Jean-François Nadaud\r\n
          \r\n
          Guilhem de Montmarin\r\n
          \r\n
          - Legal : Jeantet : Philippe Matignon\r\n
          \r\n
          Pascal Georges\r\n
          \r\n
          - Strategic : LEK : Serge Hosepian\r\n
          \r\n
          Maxime Julian\r\n
          \r\n
          - - -\r\n
          \r\n
          <strong>About LBO France</strong>\r\n
          \r\n
          As a key player in private equity with €3.6bn of capital under management, LBO France is an independent company that has been supporting French companies in their growth for more than 30 years. Its strategy is based on 4 investment approaches in non-listed assets, managed by dedicated teams: (i) Mid Cap buyout through the White Knight funds and Small Cap buyout through the Hexagone funds, (ii) Innovation-Capital through the Innovation Capital funds, (iii) Real Estate through the White Stone and Lapillus funds, (iv) Debt. LBO France is 100%-owned by its management and employs almost 60 professionals.\r\n
          \r\n
          <a href="http://www.lbofrance.com">www.lbofrance.com </a>\r\n
          \r\n
          Press Contacts For LBO France - Citigate Dewe Rogerson\r\n
          \r\n
          Robert Amady - +33 1 53 32 78 91 - +33 6 72 63 08 91 - robert.amady@citigate.fr Daiana Hirte - +33 1 53 32 78 90 - +33 7 60 90 89 12 - daiana.hirte@citigate.fr\r\n
          \r\n
          &nbsp;\r\n
          \r\n
          &nbsp;\r\n
          \r\n
          <a href="https://preprod.lbofrance.com/wp-content/uploads/2019/12/170727-lbo-france-acq-serapid-pr-final.pdf" target="_blank" rel="noopener noreferrer">Read Press Release</a>
          """
        +post_date: "2017-07-27 09:17:39"
        +post_excerpt: ""
        +post_parent: 0
        +post_status: "publish"
        +post_title: "LBO France announced the acquisition of SERAPID"
        +post_type: "post"
        +slug: "lbo-france-announced-the-acquisition-of-serapid"
        #__type: null
        +"_wpml_media_featured": "1"
        +"_wpml_media_duplicate": "1"
        +"_yoast_wpseo_content_score": "60"
        +"_wp_old_date": "2019-12-18"
        +"banner": ""
        +"_banner": "field_5d0b8f67a8a14"
        +"linkedin": ""
        +"_linkedin": "field_5d0b8fa0a8a15"
        +"fichier": ""
        +"_fichier": "field_5d0b8faba8a16"
        +"_yoast_wpseo_primary_category": ""
        +"_edit_lock": "1581430145:1"
        +"_edit_last": "1"
        +"_wp_old_slug": "lbo-france-annonce-lacquisition-de-la-societe-serapid"
        +"_last_translation_edit_mode": "native-editor"
        +"post_date_gmt": "2017-07-27 07:17:39"
        +"comment_status": "open"
        +"ping_status": "closed"
        +"post_password": ""
        +"post_name": "lbo-france-announced-the-acquisition-of-serapid"
        +"to_ping": ""
        +"pinged": ""
        +"post_modified": "2020-02-04 18:56:24"
        +"post_modified_gmt": "2020-02-04 17:56:24"
        +"post_content_filtered": ""
        +"guid": "http://preprod.lbofrance.com/lbo-france-annonce-lacquisition-de-la-societe-serapid/"
        +"menu_order": 0
        +"post_mime_type": ""
        +"comment_count": "0"
        +"filter": "raw"
        +"status": "publish"
      }
      8 => Post {#445
        +ImageClass: "Timber\Image"
        +PostClass: "Timber\Post"
        +TermClass: "Timber\Term"
        +object_type: "post"
        +custom: array:16 [
          "_wpml_media_featured" => "1"
          "_wpml_media_duplicate" => "1"
          "_yoast_wpseo_content_score" => "30"
          "_wp_old_date" => "2019-12-18"
          "banner" => ""
          "_banner" => "field_5d0b8f67a8a14"
          "linkedin" => ""
          "_linkedin" => "field_5d0b8fa0a8a15"
          "fichier" => ""
          "_fichier" => "field_5d0b8faba8a16"
          "_yoast_wpseo_primary_category" => ""
          "_edit_lock" => "1581430164:1"
          "_edit_last" => "1"
          "_wp_old_slug" => array:2 [
            0 => "lbo-france-entre-en-negociations-exclusives-avec-abenex-pour-la-reprise-du-groupe-rg-safety"
            1 => "lbo-france-enters-into-exclusive-negotiations-with-cinven-for-the-sale-of-chryso"
          ]
          "_last_translation_edit_mode" => "native-editor"
          "_wpml_media_has_media" => "1"
        ]
        #___content: null
        #_permalink: null
        #_next: []
        #_prev: []
        #_css_class: null
        +id: 2152
        +ID: 2152
        +post_author: "1"
        +post_content: """
          <strong>Paris, 26 July 2017</strong> – LBO France and Abenex announced today that they have signed an exclusive agreement aiming at the acquisition by LBO France of the majority stake in RG Safety Group (“the Group”) currently held by Abenex.\r\n
          \r\n
          Founded in 1987, headquartered in Saint Priest, and now managed by Pierre Manchini (CEO), RG Safety Group is the French leading specialized distributor of Personal Protective Equipment (PPE). The group distributes a wide range of products (35,000 references) covering 6 main protection fields: Head, Hand, Foot, Body, Breathing, and Hygiene &amp; Safety in the working environment. The Group is also successfully selling products under its own brand, Ergos, which today accounts for ca. 30% of total sales. Main clients comprise of large corporations, SMEs from the industry and service sectors and public sector entities.\r\n
          \r\n
          Operating through 27 branches (of which 20 in France), the Group employs 430 employees. In 2016, RG Safety Group saw sales growing by 17% to reach over €180M, notably further to the acquisition of Italian A+A Monferrato. International (outside France) sales now account for ca. 20% of total sales.\r\n
          \r\n
          To spur growth, RG Safety Group intends to rely on both organic and external growth to create the European leader within the PPE market by 2022, driven by:\r\n
          \r\n
          - consolidating the French PPE distribution market (market share gains, development on new segments and multi-channel offering);\r\n
          \r\n
          - expanding commercial operations in Europe with a more direct access to local clients and assistance to international clients;\r\n
          \r\n
          - integrating acquisition targets, primarily in Europe.\r\n
          \r\n
          The transaction remains subject to consultations with employee representative bodies and approval by relevant competition authorities.\r\n
          \r\n
          <strong>Jérôme Guez, Partner at LBO France</strong>, commented: <em>"We would be pleased to partner with Pierre Manchini and his teams to support RG Safety Group in its continued growth and innovation capacity, enabling it to become one of Europe’s leading distributors of Personal Protective Equipment." </em>\r\n
          \r\n
          <em>"We are very excited about the possibility to enter in a new partnership with LBO France to continue to execute the strategic plan we have initiated 3 years from now, and together, accelerate, organically and through targeted acquisitions, RG Safety Group’s growth trajectory and geographic expansion in Europe."</em> added <strong>Pierre Manchini, CEO of RG Safety Group</strong>.\r\n
          \r\n
          <strong>Johann Dupont, Partner in charge of Operating team at Abenex</strong> said: <em>"Abenex is proud to have supported the growth and development of RG Safety Group during these past 4 years, paving the way for a true European leadership." </em>\r\n
          \r\n
          Parties involved:\r\n
          \r\n
          LBO France\r\n
          \r\n
          - LBO France team: Jérôme Guez, Simon Couturier LBO Mid cap White Knight, and Gilles Taldu, Head of the Operating team\r\n
          \r\n
          - Finance : Deloitte : Frédérique Chenevoy\r\n
          \r\n
          - Legal: Mayor-Brown : Emily Pennec, Xavier Jaspar and Laurent Borey\r\n
          \r\n
          - Strategic : Advention : Alban Neveux\r\n
          \r\n
          Abenex\r\n
          \r\n
          - Abenex team: Johann Dupont and Matthieu Balaÿ\r\n
          \r\n
          - M&amp;A : Rothschild &amp; Cie (Transaction R) :\r\n
          \r\n
          o M&amp;A : Pierre Sader, Benjamin Osdoit, Guillaume Marquet de Vasselot, Cyril Petit\r\n
          \r\n
          o Financing : Mathilde Paoli\r\n
          \r\n
          - Legal : DLA Piper : Michel Frieh, Matthieu Lampel, Anaïs Vidal\r\n
          \r\n
          - Vendor Due Diligence :\r\n
          \r\n
          o Finance : Deloitte : Eric Boucharlat, Thomas Gorguis, Kevin Profit and Noémie Picaud\r\n
          \r\n
          o Legal, Social, Tax: DLA Piper : Michel Frieh, Matthieu Lampel, Anaïs Vidal, Jérôme Halphen, Eva Amor, Guillaume Valois, Emilie Renaud ;\r\n
          \r\n
          o Strategic: Indefi : Julien Berger, Charles-Antoine Dreyfus Management\r\n
          \r\n
          - Finance : Canacord : Nadim Barouki\r\n
          \r\n
          - Legal: Delaby : Emmanuel Delaby\r\n
          \r\n
          - - -\r\n
          \r\n
          <strong>About LBO France </strong>\r\n
          \r\n
          As a key player in private equity with €3.6bn of capital under management, LBO France is an independent company that has been supporting French companies in their growth for more than 30 years. Its strategy is based on 4 investment approaches in non-listed assets, managed by dedicated teams: (i) Mid Cap buyout through the White Knight funds and Small Cap buyout through the Hexagone funds, (ii) Innovation-Capital through the Innovation Capital funds, (iii) Real Estate through the White Stone and Lapillus funds, (iv) Debt. LBO France is 100%-owned by its management and employs almost 60 professionals.\r\n
          \r\n
          <a href="http://www.lbofrance.com">www.lbofrance.com</a>\r\n
          \r\n
          <strong>About RG Safety Group</strong>\r\n
          \r\n
          With more than €180 million in revenue, RG Safety Group operates through 27 branches in France and in Europe with ca. 430 employees and serves 40,000 active clients.\r\n
          \r\n
          RG Safety’s Group products cover 6 main protection fields:\r\n
          \r\n
          • Head protection (hardhats and ear defenders, goggles)\r\n
          \r\n
          • Breathing protection (masks, respirators…)\r\n
          \r\n
          • Hand protection (tear/heat/chemical resistant gloves…)\r\n
          \r\n
          • Body protection (professional, safety and short use clothing)\r\n
          \r\n
          • Foot protection (safety shoes)\r\n
          \r\n
          • Safety and hygiene (consignment and safety of the work environment…)\r\n
          \r\n
          RG Safey Group is also known through the following brand names: FIPROTEC, GERIN, AMIET, CEVENOLE DE PROTECTION in France, A+A MONFERRATO in Italy, KNOLL ARBEITSSCHUTZ in Germany, LISAP in Belgium, RG SAFETY IBERICA in Spain, RG SWISS in Switzerland, MIDITECH in Slovakia et RG Tunisia in Tunisia.\r\n
          \r\n
          <a href="http://www.groupe-rg.com">www.groupe-rg.com </a>\r\n
          \r\n
          <strong>About Abenex</strong>\r\n
          \r\n
          Abénex is a fully independent private equity firm. Abénex makes long term investments alongside managers in high growth and operational improvement transactions. Abénex specialises in capital development and buy-outs with or without financial leverage. With a strong focus on corporate strategy, operational excellence, and financial performance, Abénex leverages its network, resources and experience to help build value for customers, employees, and shareholders. The team benefits from a proven know-how in external growth projects, public-toprivate transactions, and in partnering with family owners. Abénex invests in companies valued up to €300m, either through majority or minority stakes. www.abenexcapital.com\r\n
          \r\n
          <strong>Press Contacts For LBO France</strong> - Citigate Dewe Rogerson\r\n
          \r\n
          Robert Amady - +33 1 53 32 78 91 - +33 6 72 63 08 91 - robert.amady@citigate.fr\r\n
          \r\n
          Daiana Hirte - +33 1 53 32 78 90 - +33 7 60 90 89 12 - daiana.hirte@citigate.fr\r\n
          \r\n
          <strong>For RG Safety Group </strong>\r\n
          \r\n
          Marie Patricio - +33 4 72 23 24 40 – mpatricio@groupe-rg.com\r\n
          \r\n
          <strong>For Abenex </strong>\r\n
          \r\n
          Johann Dupont - +33 1 53 93 69 04 - +33 6 23 38 46 46 - johann.dupont@abenex.com\r\n
          \r\n
          &nbsp;\r\n
          \r\n
          &nbsp;\r\n
          \r\n
          <a href="https://preprod.lbofrance.com/wp-content/uploads/2019/12/170726-lbo-france-acq-rg-safety-pr-final.pdf" target="_blank" rel="noopener noreferrer">Read Press Release</a>
          """
        +post_date: "2017-07-26 09:27:43"
        +post_excerpt: ""
        +post_parent: 0
        +post_status: "publish"
        +post_title: "LBO France enters into exclusive negotiations with Abenex for the acquisition of RG Safety Group"
        +post_type: "post"
        +slug: "lbo-france-enters-into-exclusive-negotiations-with-abenex-for-the-acquisition-of-rg-safety-group"
        #__type: null
        +"_wpml_media_featured": "1"
        +"_wpml_media_duplicate": "1"
        +"_yoast_wpseo_content_score": "30"
        +"_wp_old_date": "2019-12-18"
        +"banner": ""
        +"_banner": "field_5d0b8f67a8a14"
        +"linkedin": ""
        +"_linkedin": "field_5d0b8fa0a8a15"
        +"fichier": ""
        +"_fichier": "field_5d0b8faba8a16"
        +"_yoast_wpseo_primary_category": ""
        +"_edit_lock": "1581430164:1"
        +"_edit_last": "1"
        +"_wp_old_slug": array:2 [
          0 => "lbo-france-entre-en-negociations-exclusives-avec-abenex-pour-la-reprise-du-groupe-rg-safety"
          1 => "lbo-france-enters-into-exclusive-negotiations-with-cinven-for-the-sale-of-chryso"
        ]
        +"_last_translation_edit_mode": "native-editor"
        +"_wpml_media_has_media": "1"
        +"post_date_gmt": "2017-07-26 07:27:43"
        +"comment_status": "open"
        +"ping_status": "closed"
        +"post_password": ""
        +"post_name": "lbo-france-enters-into-exclusive-negotiations-with-abenex-for-the-acquisition-of-rg-safety-group"
        +"to_ping": ""
        +"pinged": ""
        +"post_modified": "2020-02-04 19:04:24"
        +"post_modified_gmt": "2020-02-04 18:04:24"
        +"post_content_filtered": ""
        +"guid": "http://preprod.lbofrance.com/lbo-france-entre-en-negociations-exclusives-avec-abenex-pour-la-reprise-du-groupe-rg-safety/"
        +"menu_order": 0
        +"post_mime_type": ""
        +"comment_count": "0"
        +"filter": "raw"
        +"status": "publish"
      }
    ]
  }
  "wp_head" => FunctionWrapper {#425
    -_class: null
    -_function: "wp_head"
    -_args: []
    -_use_ob: false
  }
  "wp_footer" => FunctionWrapper {#7820
    -_class: null
    -_function: "wp_footer"
    -_args: []
    -_use_ob: false
  }
]